BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Häberle J, Boddaert N, Burlina A, Chakrapani A, Dixon M, Huemer M, Karall D, Martinelli D, Crespo PS, Santer R, Servais A, Valayannopoulos V, Lindner M, Rubio V, Dionisi-Vici C. Suggested guidelines for the diagnosis and management of urea cycle disorders. Orphanet J Rare Dis 2012;7:32. [PMID: 22642880 DOI: 10.1186/1750-1172-7-32] [Cited by in Crossref: 350] [Cited by in F6Publishing: 261] [Article Influence: 35.0] [Reference Citation Analysis]
Number Citing Articles
1 Tanaka K, Nakamura K, Matsumoto S, Kido J, Mitsubuchi H, Ohura T, Endo F. Citrulline for urea cycle disorders in Japan. Pediatrics International 2017;59:422-6. [DOI: 10.1111/ped.13163] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
2 Mazariegos G, Shneider B, Burton B, Fox IJ, Hadzic N, Kishnani P, Morton DH, McIntire S, Sokol RJ, Summar M, White D, Chavanon V, Vockley J. Liver transplantation for pediatric metabolic disease. Mol Genet Metab 2014;111:418-27. [PMID: 24495602 DOI: 10.1016/j.ymgme.2014.01.006] [Cited by in Crossref: 65] [Cited by in F6Publishing: 49] [Article Influence: 8.1] [Reference Citation Analysis]
3 Borgmann K, Ghorpade A. HIV-1, methamphetamine and astrocytes at neuroinflammatory Crossroads. Front Microbiol 2015;6:1143. [PMID: 26579077 DOI: 10.3389/fmicb.2015.01143] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 4.1] [Reference Citation Analysis]
4 Silfverberg T, Sahlander F, Enlund M, Oscarson M, Hårdstedt M. Late onset hyperornithinemia-hyperammonemia-homocitrullinuria syndrome - how web searching by the family solved unexplained unconsciousness: a case report. J Med Case Rep 2018;12:274. [PMID: 30243302 DOI: 10.1186/s13256-018-1794-9] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
5 Fabie NAV, Pappas KB, Feldman GL. The Current State of Newborn Screening in the United States. Pediatr Clin North Am 2019;66:369-86. [PMID: 30819343 DOI: 10.1016/j.pcl.2018.12.007] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
6 Tarasenko TN, McGuire PJ. The liver is a metabolic and immunologic organ: A reconsideration of metabolic decompensation due to infection in inborn errors of metabolism (IEM). Mol Genet Metab 2017;121:283-8. [PMID: 28666653 DOI: 10.1016/j.ymgme.2017.06.010] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
7 Agostoni V, Lee SH, Forster V, Kabbaj M, Bosoi CR, Tremblay M, Zadory M, Rose CF, Leroux J. Liposome-Supported Peritoneal Dialysis for the Treatment of Hyperammonemia-Associated Encephalopathy. Adv Funct Mater 2016;26:8382-9. [DOI: 10.1002/adfm.201603519] [Cited by in Crossref: 18] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
8 Sandlers Y. Amino Acids Profiling for the Diagnosis of Metabolic Disorders. In: Bobbarala V, Sarwar Zaman G, Nasir Mohd Desa M, Md Akim A, editors. Biochemical Testing - Clinical Correlation and Diagnosis. IntechOpen; 2020. [DOI: 10.5772/intechopen.84672] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
9 Rüfenacht V, Häberle J. Mini-Review: Challenges in Newborn Screening for Urea Cycle Disorders. IJNS 2015;1:27-35. [DOI: 10.3390/ijns1010027] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
10 Cavicchi C, Donati M, Parini R, Rigoldi M, Bernardi M, Orfei F, Gentiloni Silveri N, Colasante A, Funghini S, Catarzi S, Pasquini E, la Marca G, Mooney S, Guerrini R, Morrone A. Sudden unexpected fatal encephalopathy in adults with OTC gene mutations-Clues for early diagnosis and timely treatment. Orphanet J Rare Dis 2014;9:105. [PMID: 25026867 DOI: 10.1186/s13023-014-0105-9] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.9] [Reference Citation Analysis]
11 Markus C, Metz M. Comparison of plasma ammonia results from seven different automated platforms in use throughout Central Australia. Clin Biochem 2017;50:331-5. [PMID: 27913270 DOI: 10.1016/j.clinbiochem.2016.11.025] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
12 Meyburg J, Opladen T, Spiekerkötter U, Schlune A, Schenk JP, Schmidt J, Weitz J, Okun J, Bürger F, Omran TB, Abdoh G, Al Rifai H, Monavari A, Konstantopoulou V, Kölker S, Yudkoff M, Hoffmann GF. Human heterologous liver cells transiently improve hyperammonemia and ureagenesis in individuals with severe urea cycle disorders. J Inherit Metab Dis 2018;41:81-90. [PMID: 29027067 DOI: 10.1007/s10545-017-0097-4] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
13 Stockler-Ipsiroglu S, Potter BK, Yuskiv N, Tingley K, Patterson M, van Karnebeek C. Developments in evidence creation for treatments of inborn errors of metabolism. J Inherit Metab Dis 2021;44:88-98. [PMID: 32944978 DOI: 10.1002/jimd.12315] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
14 Cunningham SC, Siew SM, Hallwirth CV, Bolitho C, Sasaki N, Garg G, Michael IP, Hetherington NA, Carpenter K, de Alencastro G, Nagy A, Alexander IE. Modeling correction of severe urea cycle defects in the growing murine liver using a hybrid recombinant adeno-associated virus/piggyBac transposase gene delivery system. Hepatology 2015;62:417-28. [PMID: 26011400 DOI: 10.1002/hep.27842] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 2.7] [Reference Citation Analysis]
15 Yahyaoui R, Pérez-Frías J. Amino Acid Transport Defects in Human Inherited Metabolic Disorders. Int J Mol Sci 2019;21:E119. [PMID: 31878022 DOI: 10.3390/ijms21010119] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
16 Santos CD, Ratzlaff RA, Meder JC, Atwal PS, Joyce NE. Ornithine Transcarbamylase Deficiency: If at First You Do Not Diagnose, Try and Try Again. Case Rep Crit Care 2017;2017:8724810. [PMID: 29279777 DOI: 10.1155/2017/8724810] [Reference Citation Analysis]
17 Parker D, Sanders EJ, Burghardt KJ. Pharmacogenetics of antiepileptic drugs: A brief review. Ment Health Clin 2016;6:28-34. [PMID: 29955444 DOI: 10.9740/mhc.2016.01.028] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
18 Shi D, Zhao G, Ah Mew N, Tuchman M. Precision medicine in rare disease: Mechanisms of disparate effects of N-carbamyl-l-glutamate on mutant CPS1 enzymes. Mol Genet Metab 2017;120:198-206. [PMID: 28007335 DOI: 10.1016/j.ymgme.2016.12.002] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
19 Moedas M, Adam A, Farelo M, Ijlst L, Chamuleau R, Hoekstra R, Wanders R, Silva M. Advances in methods for characterization of hepatic urea cycle enzymatic activity in HepaRG cells using UPLC-MS/MS. Analytical Biochemistry 2017;535:47-55. [DOI: 10.1016/j.ab.2017.07.025] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 2.2] [Reference Citation Analysis]
20 Shaik M, Kamate M, Kruthika-Vinod TP, Vedamurthy AB. A Low-Excretor Biochemical Phenotype of Glutaric Aciduria Type I: Identification of Novel Mutations in the Glutaryl CoA Dehydrogenase Gene and Review of Literature from India. Ann Indian Acad Neurol 2020;23:724-6. [PMID: 33623287 DOI: 10.4103/aian.AIAN_188_19] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
21 Bigot A, Brunault P, Lavigne C, Feillet F, Odent S, Kaphan E, Thauvin C, Leguy V, Broué P, Tchan MC, Maillot F. Psychiatric adult-onset of urea cycle disorders: A case-series. Mol Genet Metab Rep 2017;12:103-9. [PMID: 28725569 DOI: 10.1016/j.ymgmr.2017.07.001] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 2.4] [Reference Citation Analysis]
22 Burrage LC, Thistlethwaite L, Stroup BM, Sun Q, Miller MJ, Nagamani SCS, Craigen W, Scaglia F, Sutton VR, Graham B, Kennedy AD, Milosavljevic A, Lee BH, Elsea SH; Members of the UCDC,. Untargeted metabolomic profiling reveals multiple pathway perturbations and new clinical biomarkers in urea cycle disorders. Genet Med 2019;21:1977-86. [PMID: 30670878 DOI: 10.1038/s41436-019-0442-0] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 7.0] [Reference Citation Analysis]
23 Takayanagi M. A commentary on short-term efficacy of N-carbamylglutamate in a patient with N-acetylglutamate synthase deficiency. J Hum Genet 2015;60:347. [PMID: 25994872 DOI: 10.1038/jhg.2015.38] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
24 Heibel SK, McGuire PJ, Haskins N, Majumdar HD, Rayavarapu S, Nagaraju K, Hathout Y, Brown K, Tuchman M, Caldovic L. AMP-activated protein kinase signaling regulated expression of urea cycle enzymes in response to changes in dietary protein intake. J Inherit Metab Dis 2019;42:1088-96. [PMID: 31177541 DOI: 10.1002/jimd.12133] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
25 Miranda GM, Marcon NAP, Basso CF, Jorge Júnior LA, Queiroz RM. Acute hyperammonemic encephalopathy secondary to ornithine transcarbamylase deficiency in a child: findings in diagnostic imaging. Arq Neuropsiquiatr 2019;77:834-5. [PMID: 31826142 DOI: 10.1590/0004-282X20190117] [Reference Citation Analysis]
26 Ashe K, Kelso W, Farrand S, Panetta J, Fazio T, De Jong G, Walterfang M. Psychiatric and Cognitive Aspects of Phenylketonuria: The Limitations of Diet and Promise of New Treatments. Front Psychiatry 2019;10:561. [PMID: 31551819 DOI: 10.3389/fpsyt.2019.00561] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
27 Posset R, Gropman AL, Nagamani SCS, Burrage LC, Bedoyan JK, Wong D, Berry GT, Baumgartner MR, Yudkoff M, Zielonka M, Hoffmann GF, Burgard P, Schulze A, McCandless SE, Garcia-Cazorla A, Seminara J, Garbade SF, Kölker S; Urea Cycle Disorders Consortium and the European Registry and Network for Intoxication Type Metabolic Diseases Consortia Study Group. Impact of Diagnosis and Therapy on Cognitive Function in Urea Cycle Disorders. Ann Neurol 2019;86:116-28. [PMID: 31018246 DOI: 10.1002/ana.25492] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
28 Macdonald A, van Rijn M, Feillet F, Lund A, Bernstein L, Bosch A, Gizewska M, van Spronsen F. Adherence Issues in Inherited Metabolic Disorders Treated by Low Natural Protein Diets. Ann Nutr Metab 2012;61:289-95. [DOI: 10.1159/000342256] [Cited by in Crossref: 33] [Cited by in F6Publishing: 33] [Article Influence: 3.3] [Reference Citation Analysis]
29 Brassier A, Gobin S, Arnoux JB, Valayannopoulos V, Habarou F, Kossorotoff M, Servais A, Barbier V, Dubois S, Touati G, Barouki R, Lesage F, Dupic L, Bonnefont JP, Ottolenghi C, De Lonlay P. Long-term outcomes in Ornithine Transcarbamylase deficiency: a series of 90 patients. Orphanet J Rare Dis 2015;10:58. [PMID: 25958381 DOI: 10.1186/s13023-015-0266-1] [Cited by in Crossref: 40] [Cited by in F6Publishing: 34] [Article Influence: 5.7] [Reference Citation Analysis]
30 Soria LR, Ah Mew N, Brunetti-Pierri N. Progress and challenges in development of new therapies for urea cycle disorders. Hum Mol Genet 2019;28:R42-8. [PMID: 31227828 DOI: 10.1093/hmg/ddz140] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
31 Ray SK, Mukherjee S. Molecular and biochemical investigations of inborn errors of metabolism-altered redox homeostasis in branched-chain amino acid disorders, organic acidurias, and homocystinuria. Free Radic Res 2021;:1-14. [PMID: 33504220 DOI: 10.1080/10715762.2021.1877286] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
32 Singh S, Pal S, Dubrey SW. Unusual cause of general malaise: a young woman with ornithine transcarbamylase deficiency. BMJ Case Rep 2016;2016:bcr2015213768. [PMID: 26791129 DOI: 10.1136/bcr-2015-213768] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
33 Janwadkar A, Shirole N, Nagral A, Bakshi R, Vasanth S, Bagde A, Yewale V, Mirza D. Citrullinemia Type 1: Behavioral Improvement with Late Liver Transplantation. Indian J Pediatr 2019;86:639-41. [DOI: 10.1007/s12098-019-02905-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
34 Kwon JM, Matern D, Kurtzberg J, Wrabetz L, Gelb MH, Wenger DA, Ficicioglu C, Waldman AT, Burton BK, Hopkins PV, Orsini JJ. Consensus guidelines for newborn screening, diagnosis and treatment of infantile Krabbe disease. Orphanet J Rare Dis 2018;13:30. [PMID: 29391017 DOI: 10.1186/s13023-018-0766-x] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 6.8] [Reference Citation Analysis]
35 Del Río C, Martín-Hernández E, Ruiz A, Quijada-Fraile P, Rubio P. Perioperative management of children with urea cycle disorders. Paediatr Anaesth 2020;30:780-91. [PMID: 32375202 DOI: 10.1111/pan.13905] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
36 Mei L, Song P, Kokudo N, Xu L, Tang W. Current situation and prospects of newborn screening and treatment for Phenylketonuria in China - compared with the current situation in the United States, UK and Japan. Intractable Rare Dis Res 2013;2:106-14. [PMID: 25343113 DOI: 10.5582/irdr.2013.v2.4.106] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
37 Ho B, MacKenzie J, Walia J, Geraghty M, Smith G, Nedvidek J, Guerin A. Hyperornithinemia-hyperammonemia-homocitrullinuria syndrome in pregnancy: Considerations for management and review of the literature. JIMD Rep 2019;46:28-34. [PMID: 31240152 DOI: 10.1002/jmd2.12025] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
38 Stepien KM, Geberhiwot T, Hendriksz CJ, Treacy EP. Challenges in diagnosing and managing adult patients with urea cycle disorders. J Inherit Metab Dis 2019;42:1136-46. [PMID: 30932189 DOI: 10.1002/jimd.12096] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 3.7] [Reference Citation Analysis]
39 Diez-Fernandez C, Häberle J. Targeting CPS1 in the treatment of Carbamoyl phosphate synthetase 1 (CPS1) deficiency, a urea cycle disorder. Expert Opin Ther Targets 2017;21:391-9. [PMID: 28281899 DOI: 10.1080/14728222.2017.1294685] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 5.0] [Reference Citation Analysis]
40 Tchan M. Hyperammonemia and lactic acidosis in adults: Differential diagnoses with a focus on inborn errors of metabolism. Rev Endocr Metab Disord. 2018;19:69-79. [PMID: 29497930 DOI: 10.1007/s11154-018-9444-5] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
41 Dufour DR. Commentary. Clin Chem 2016;62:1568-9. [PMID: 27899454 DOI: 10.1373/clinchem.2016.263566] [Reference Citation Analysis]
42 Patel R. Metabolic disorders: an overview and key messages for pharmacists. Eur J Hosp Pharm 2014;21:355-60. [DOI: 10.1136/ejhpharm-2013-000398] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
43 Maillot F, Blasco H, Lioger B, Bigot A, Douillard C. [Diagnosis and treatment of urea cycle disorders in adult patients]. Rev Med Interne 2016;37:680-4. [PMID: 27032484 DOI: 10.1016/j.revmed.2016.02.011] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
44 Mace H, Srinivas C, Selzner M, Minkovich L. Anesthetic management of a patient with arginase deficiency undergoing liver transplantation. A A Case Rep 2014;3:85-7. [PMID: 25611620 DOI: 10.1213/XAA.0000000000000066] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
45 Cassis L, Cortès-Saladelafont E, Molero-Luis M, Yubero D, González MJ, Ormazábal A, Fons C, Jou C, Sierra C, Castejon Ponce E, Ramos F, Armstrong J, O'Callaghan MM, Casado M, Montero R, Meavilla-Olivas S, Artuch R, Barić I, Bartoloni F, Bellettato CM, Bonifazi F, Ceci A, Cvitanović-Šojat L, Dali CI, D'Avanzo F, Fumic K, Giannuzzi V, Lampe C, Scarpa M, Garcia-Cazorla Á. Review and evaluation of the methodological quality of the existing guidelines and recommendations for inherited neurometabolic disorders. Orphanet J Rare Dis 2015;10:164. [PMID: 26714856 DOI: 10.1186/s13023-015-0376-9] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
46 Ah Mew N, Cnaan A, McCarter R, Choi H, Glass P, Rice K, Scavo L, Gillespie CW, Diaz GA, Berry GT, Wong D, Konczal L, McCandless SE, Coughlin Ii CR, Weisfeld-Adams JD, Ficicioglu C, Yudkoff M, Enns GM, Lichter-Konecki U, Gallagher R, Tuchman M. Conducting an investigator-initiated randomized double-blinded intervention trial in acute decompensation of inborn errors of metabolism: Lessons from the N-Carbamylglutamate Consortium. Transl Sci Rare Dis 2018;3:157-70. [PMID: 30613471 DOI: 10.3233/TRD-180031] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
47 Boneh A. Dietary protein in urea cycle defects: How much? Which? How? Molecular Genetics and Metabolism 2014;113:109-12. [DOI: 10.1016/j.ymgme.2014.04.009] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
48 Lazier J, Lupichuk SM, Sosova I, Khan AA. Hyperammonemic encephalopathy in an adenocarcinoma patient managed with carglumic acid. Curr Oncol 2014;21:e736-9. [PMID: 25302046 DOI: 10.3747/co.21.2076] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
49 Gascon-Bayarri J, Campdelacreu J, Estela J, Reñé R. Severe hyperammonemia in late-onset ornithine transcarbamylase deficiency triggered by steroid administration. Case Rep Neurol Med 2015;2015:453752. [PMID: 25949836 DOI: 10.1155/2015/453752] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
50 Ginocchio VM, Brunetti-Pierri N. Progress toward improved therapies for inborn errors of metabolism. Hum Mol Genet 2016;25:R27-35. [PMID: 26443595 DOI: 10.1093/hmg/ddv418] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
51 van Straten G, de Sain-van der Velden MGM, van Geijlswijk IM, Favier RP, Mesu SJ, Holwerda-Loof NE, van der Ham M, Fieten H, Rothuizen J, Spee B, Verhoeven-Duif NM. Saline is as effective as nitrogen scavengers for treatment of hyperammonemia. Sci Rep 2017;7:13112. [PMID: 29030642 DOI: 10.1038/s41598-017-12686-9] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
52 Elsayed LEO, Mohammed IN, Hamed AAA, Elseed MA, Salih MAM, Yahia A, Abubaker R, Koko M, Abd Allah ASI, Elbashir MI, Ibrahim ME, Brice A, Ahmed AE, Stevanin G. Novel Homozygous Missense Mutation in the ARG1 Gene in a Large Sudanese Family. Front Neurol 2020;11:569996. [PMID: 33193012 DOI: 10.3389/fneur.2020.569996] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
53 Khoory J, Rupal A, Jani C, Singh H, Hu K. Food Coma: Hyperammonemic Encephalopathy From Refeeding Syndrome. Cureus 2021;13:e18898. [PMID: 34820220 DOI: 10.7759/cureus.18898] [Reference Citation Analysis]
54 Kose E, Kuyum P, Aksoy B, Häberle J, Arslan N, Ozturk Y. First report of carglumic acid in a patient with citrullinemia type 1 (argininosuccinate synthetase deficiency). J Clin Pharm Ther 2018;43:124-8. [PMID: 28741715 DOI: 10.1111/jcpt.12593] [Cited by in Crossref: 4] [Article Influence: 0.8] [Reference Citation Analysis]
55 Raina R, Bedoyan JK, Lichter-Konecki U, Jouvet P, Picca S, Mew NA, Machado MC, Chakraborty R, Vemuganti M, Grewal MK, Bunchman T, Sethi SK, Krishnappa V, McCulloch M, Alhasan K, Bagga A, Basu RK, Schaefer F, Filler G, Warady BA. Consensus guidelines for management of hyperammonaemia in paediatric patients receiving continuous kidney replacement therapy. Nat Rev Nephrol 2020;16:471-82. [PMID: 32269302 DOI: 10.1038/s41581-020-0267-8] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 4.5] [Reference Citation Analysis]
56 Brossier D, Goyer I, Ziani L, Marquis C, Mitchell G, Ozanne B, Jouvet P. Influence of implementing a protocol for an intravenously administered ammonia scavenger on the management of acute hyperammonemia in a pediatric intensive care unit. J Inherit Metab Dis. 2019;42:77-85. [PMID: 30740742 DOI: 10.1002/jimd.12029] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
57 Kim JS, Kim KM, Oh SH, Kim HJ, Cho JM, Yoo HW, Namgoong JM, Kim DY, Kim KH, Hwang S, Lee SG. Liver transplantation for metabolic liver disease: experience at a living donor dominant liver transplantation center. Pediatr Gastroenterol Hepatol Nutr. 2015;18:48-54. [PMID: 25866733 DOI: 10.5223/pghn.2015.18.1.48] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
58 Humphrey M, Truby H, Boneh A. New ways of defining protein and energy relationships in inborn errors of metabolism. Molecular Genetics and Metabolism 2014;112:247-58. [DOI: 10.1016/j.ymgme.2014.05.008] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
59 Longo N, Holt RJ. Glycerol phenylbutyrate for the maintenance treatment of patients with deficiencies in enzymes of the urea cycle. Expert Opinion on Orphan Drugs 2017;5:999-1010. [DOI: 10.1080/21678707.2017.1405807] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
60 Dercksen M, IJlst L, Duran M, Mienie LJ, van Cruchten A, van der Westhuizen FH, Wanders RJ. Inhibition of N-acetylglutamate synthase by various monocarboxylic and dicarboxylic short-chain coenzyme A esters and the production of alternative glutamate esters. Biochim Biophys Acta 2014;1842:2510-6. [PMID: 23643712 DOI: 10.1016/j.bbadis.2013.04.027] [Cited by in Crossref: 24] [Cited by in F6Publishing: 19] [Article Influence: 2.7] [Reference Citation Analysis]
61 Ayyub OB, Behrens AM, Heligman BT, Natoli ME, Ayoub JJ, Cunningham G, Summar M, Kofinas P. Simple and inexpensive quantification of ammonia in whole blood. Mol Genet Metab 2015;115:95-100. [PMID: 25936660 DOI: 10.1016/j.ymgme.2015.04.004] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
62 Singh P, Chung HJ, Lee IA, D'Souza R, Kim HJ, Hong ST. Elucidation of the anti-hyperammonemic mechanism of Lactobacillus amylovorus JBD401 by comparative genomic analysis. BMC Genomics 2018;19:292. [PMID: 29695242 DOI: 10.1186/s12864-018-4672-3] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
63 Balmer C, Pandey AV, Rüfenacht V, Nuoffer J, Fang P, Wong L, Häberle J. Mutations and Polymorphisms in the Human Argininosuccinate Lyase ( ASL ) Gene. Human Mutation 2014;35:27-35. [DOI: 10.1002/humu.22469] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 3.0] [Reference Citation Analysis]
64 Alhashem AM, Salih RM, Al-Aqeel AI, Mohamed S. Peripheral venous route for administration of ammonul infusion for treatment of acute hyperammonemia. An experience from a tertiary center in Saudi Arabia. Saudi Med J 2020;41:98-101. [PMID: 31915802 DOI: 10.15537/smj.2020.1.24760] [Reference Citation Analysis]
65 Ferriero R, Iannuzzi C, Manco G, Brunetti-Pierri N. Differential inhibition of PDKs by phenylbutyrate and enhancement of pyruvate dehydrogenase complex activity by combination with dichloroacetate. J Inherit Metab Dis 2015;38:895-904. [PMID: 25601413 DOI: 10.1007/s10545-014-9808-2] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 4.0] [Reference Citation Analysis]
66 Bennett J, Gilkes C, Klassen K, Kerr M, Khan A. Two Siblings With Valproate-Related Hyperammonemia and Novel Mutations in Glutamine Synthetase (GLUL) Treated With Carglumic Acid. Child Neurol Open 2020;7:2329048X20967880. [PMID: 33150193 DOI: 10.1177/2329048X20967880] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
67 Summar ML, Endo F, Kölker S. On the Creation, Utility and Sustaining of Rare Diseases Research Networks: Lessons learned from the Urea Cycle Disorders Consortium, the Japanese Urea Cycle Disorders Consortium and the European Registry and Network for Intoxication Type Metabolic Diseases. Mol Genet Metab 2014;113:105-8. [PMID: 25261246 DOI: 10.1016/j.ymgme.2014.09.002] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.1] [Reference Citation Analysis]
68 Ali EZ, Yakob Y, Ngu LH. Identification of mutations in Malaysian patients with argininosuccinate lyase (ASL) deficiency. Mol Genet Metab Rep 2019;21:100525. [PMID: 31709144 DOI: 10.1016/j.ymgmr.2019.100525] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
69 Breilyn MS, Wasserstein MP. Established and Emerging Treatments for Patients with Inborn Errors of Metabolism. Neoreviews 2020;21:e699-707. [PMID: 33004565 DOI: 10.1542/neo.21-10-e699] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
70 Zielonka M, Breuer M, Okun JG, Carl M, Hoffmann GF, Kölker S. Pharmacologic rescue of hyperammonemia-induced toxicity in zebrafish by inhibition of ornithine aminotransferase. PLoS One 2018;13:e0203707. [PMID: 30199544 DOI: 10.1371/journal.pone.0203707] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
71 Burgard P, Kölker S, Haege G, Lindner M, Hoffmann GF. Neonatal mortality and outcome at the end of the first year of life in early onset urea cycle disorders—review and meta-analysis of observational studies published over more than 35 years. J Inherit Metab Dis 2016;39:219-29. [DOI: 10.1007/s10545-015-9901-1] [Cited by in Crossref: 32] [Cited by in F6Publishing: 30] [Article Influence: 4.6] [Reference Citation Analysis]
72 Farelli JD, Asrani KH, Isaacs C, deBear JS, Stahley MR, Shah A, Lasaro MA, Cheng CJ, Subramanian RR. Leveraging Rational Protein Engineering to Improve mRNA Therapeutics. Nucleic Acid Ther 2018;28:74-85. [PMID: 29437538 DOI: 10.1089/nat.2017.0697] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
73 Schrettl V, Felgenhauer N, Rabe C, Fernando M, Eyer F. L-Arginine in the treatment of valproate overdose - five clinical cases. Clin Toxicol (Phila) 2017;55:260-6. [PMID: 28152637 DOI: 10.1080/15563650.2017.1284333] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 1.2] [Reference Citation Analysis]
74 Osaka S, Nakano S, Mizuno T, Hiraoka Y, Minowa K, Hirai S, Mizutani A, Sabu Y, Miura Y, Shimizu T, Kusuhara H, Suzuki M, Hayashi H. A randomized trial to examine the impact of food on pharmacokinetics of 4-phenylbutyrate and change in amino acid availability after a single oral administration of sodium 4-phenylbutyrarte in healthy volunteers. Mol Genet Metab 2021;132:220-6. [PMID: 33648834 DOI: 10.1016/j.ymgme.2021.02.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
75 Yu J, Liu JY, Xiong WM, Zhang XY, Zheng Y. Binding interaction of sodium benzoate food additive with bovine serum albumin: multi-spectroscopy and molecular docking studies. BMC Chem 2019;13:95. [PMID: 31355368 DOI: 10.1186/s13065-019-0615-6] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
76 Vockley J, Chapman KA, Arnold GL. Development of clinical guidelines for inborn errors of metabolism: commentary. Mol Genet Metab 2013;108:203-5. [PMID: 23428739 DOI: 10.1016/j.ymgme.2013.01.013] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
77 Ashley SN, Nordin JML, Buza EL, Greig JA, Wilson JM. Adeno-associated viral gene therapy corrects a mouse model of argininosuccinic aciduria. Mol Genet Metab 2018;125:241-50. [PMID: 30253962 DOI: 10.1016/j.ymgme.2018.08.013] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
78 Summar ML, Mew NA. Inborn Errors of Metabolism with Hyperammonemia. Pediatric Clinics of North America 2018;65:231-46. [DOI: 10.1016/j.pcl.2017.11.004] [Cited by in Crossref: 22] [Cited by in F6Publishing: 17] [Article Influence: 5.5] [Reference Citation Analysis]
79 Couchet M, Breuillard C, Corne C, Rendu J, Morio B, Schlattner U, Moinard C. Ornithine Transcarbamylase - From Structure to Metabolism: An Update. Front Physiol 2021;12:748249. [PMID: 34658931 DOI: 10.3389/fphys.2021.748249] [Reference Citation Analysis]
80 Sugiyama Y, Shimura M, Ogawa-Tominaga M, Ebihara T, Kinouchi Y, Isozaki K, Matsuhashi T, Tajika M, Fushimi T, Ichimoto K, Matsunaga A, Ishida T, Mizutani K, Tsuruoka T, Murayama K. Therapeutic effect of N-carbamylglutamate in CPS1 deficiency. Mol Genet Metab Rep 2020;24:100622. [PMID: 32670798 DOI: 10.1016/j.ymgmr.2020.100622] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
81 Barkovich E, Gropman AL. Late Onset Ornithine Transcarbamylase Deficiency Triggered by an Acute Increase in Protein Intake: A Review of 10 Cases Reported in the Literature. Case Rep Genet 2020;2020:7024735. [PMID: 32373372 DOI: 10.1155/2020/7024735] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
82 Olivieri G, Pro S, Diodato D, Di Capua M, Longo D, Martinelli D, Bertini E, Dionisi-Vici C. Corticospinal tract damage in HHH syndrome: a metabolic cause of hereditary spastic paraplegia. Orphanet J Rare Dis 2019;14:208. [PMID: 31443672 DOI: 10.1186/s13023-019-1181-7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
83 Baruteau J, Perocheau DP, Hanley J, Lorvellec M, Rocha-Ferreira E, Karda R, Ng J, Suff N, Diaz JA, Rahim AA, Hughes MP, Banushi B, Prunty H, Hristova M, Ridout DA, Virasami A, Heales S, Howe SJ, Buckley SMK, Mills PB, Gissen P, Waddington SN. Argininosuccinic aciduria fosters neuronal nitrosative stress reversed by Asl gene transfer. Nat Commun 2018;9:3505. [PMID: 30158522 DOI: 10.1038/s41467-018-05972-1] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 4.8] [Reference Citation Analysis]
84 Matoori S, Bao Y, Schmidt A, Fischer EJ, Ochoa-Sanchez R, Tremblay M, Oliveira MM, Rose CF, Leroux JC. An Investigation of PS-b-PEO Polymersomes for the Oral Treatment and Diagnosis of Hyperammonemia. Small 2019;15:e1902347. [PMID: 31721441 DOI: 10.1002/smll.201902347] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 3.7] [Reference Citation Analysis]
85 Brambilla A, Bianchi ML, Cancello R, Galimberti C, Gasperini S, Pretese R, Rigoldi M, Tursi S, Parini R. Resting energy expenditure in argininosuccinic aciduria and in other urea cycle disorders. J Inherit Metab Dis 2019;42:1105-17. [PMID: 31056765 DOI: 10.1002/jimd.12108] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
86 Cavicchi C, Chilleri C, Fioravanti A, Ferri L, Ripandelli F, Costa C, Calabresi P, Prontera P, Pochiero F, Pasquini E, Funghini S, la Marca G, Donati MA, Morrone A. Late-Onset N-Acetylglutamate Synthase Deficiency: Report of a Paradigmatic Adult Case Presenting with Headaches and Review of the Literature. Int J Mol Sci 2018;19:E345. [PMID: 29364180 DOI: 10.3390/ijms19020345] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
87 Soria LR, Nitzahn M, De Angelis A, Khoja S, Attanasio S, Annunziata P, Palmer DJ, Ng P, Lipshutz GS, Brunetti-Pierri N. Hepatic glutamine synthetase augmentation enhances ammonia detoxification. J Inherit Metab Dis 2019;42:1128-35. [PMID: 30724386 DOI: 10.1002/jimd.12070] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
88 Picca S, Dionisi-vici C, Bartuli A, De Palo T, Papadia F, Montini G, Materassi M, Donati MA, Verrina E, Schiaffino MC, Pecoraro C, Iaccarino E, Vidal E, Burlina A, Emma F. Short-term survival of hyperammonemic neonates treated with dialysis. Pediatr Nephrol 2015;30:839-47. [DOI: 10.1007/s00467-014-2945-x] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 3.4] [Reference Citation Analysis]
89 Gobin-Limballe S, Ottolenghi C, Reyal F, Arnoux JB, Magen M, Simon M, Brassier A, Jabot-Hanin F, Lonlay P, Pontoizeau C, Guirat M, Rio M, Gesny R, Gigarel N, Royer G, Steffann J, Munnich A, Bonnefont JP. OTC deficiency in females: Phenotype-genotype correlation based on a 130-family cohort. J Inherit Metab Dis 2021;44:1235-47. [PMID: 34014569 DOI: 10.1002/jimd.12404] [Reference Citation Analysis]
90 Ebrahimi-Fakhari D, Saffari A, Pearl PL. Childhood-onset hereditary spastic paraplegia and its treatable mimics. Mol Genet Metab 2021:S1096-7192(21)00735-6. [PMID: 34183250 DOI: 10.1016/j.ymgme.2021.06.006] [Reference Citation Analysis]
91 Posset R, Garbade SF, Gleich F, Gropman AL, de Lonlay P, Hoffmann GF, Garcia-Cazorla A, Nagamani SCS, Baumgartner MR, Schulze A, Dobbelaere D, Yudkoff M, Kölker S, Zielonka M; Urea Cycle Disorders Consortium (UCDC)., European registry and network for Intoxication type Metabolic Diseases (E-IMD). Long-term effects of medical management on growth and weight in individuals with urea cycle disorders. Sci Rep 2020;10:11948. [PMID: 32686765 DOI: 10.1038/s41598-020-67496-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
92 Rodan LH, Aldubayan SH, Berry GT, Levy HL. Acute Illness Protocol for Urea Cycle Disorders. Pediatr Emerg Care 2018;34:e115-9. [PMID: 29135898 DOI: 10.1097/PEC.0000000000001298] [Cited by in Crossref: 2] [Article Influence: 0.5] [Reference Citation Analysis]
93 Fan L, Zhao J, Jiang L, Xie L, Ma J, Li X, Cheng M. Molecular, biochemical, and clinical analyses of five patients with carbamoyl phosphate synthetase 1 deficiency. J Clin Lab Anal 2020;34:e23124. [PMID: 31749211 DOI: 10.1002/jcla.23124] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
94 Pratsinis A, Devuyst O, Leroux J. Peritoneal dialysis beyond kidney failure? Journal of Controlled Release 2018;282:3-12. [DOI: 10.1016/j.jconrel.2018.01.017] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
95 Rüegger CM, Lindner M, Ballhausen D, Baumgartner MR, Beblo S, Das A, Gautschi M, Glahn EM, Grünert SC, Hennermann J, Hochuli M, Huemer M, Karall D, Kölker S, Lachmann RH, Lotz-Havla A, Möslinger D, Nuoffer JM, Plecko B, Rutsch F, Santer R, Spiekerkoetter U, Staufner C, Stricker T, Wijburg FA, Williams M, Burgard P, Häberle J. Cross-sectional observational study of 208 patients with non-classical urea cycle disorders. J Inherit Metab Dis 2014;37:21-30. [PMID: 23780642 DOI: 10.1007/s10545-013-9624-0] [Cited by in Crossref: 43] [Cited by in F6Publishing: 42] [Article Influence: 4.8] [Reference Citation Analysis]
96 Liebe R, Esposito I, Bock HH, Vom Dahl S, Stindt J, Baumann U, Luedde T, Keitel V. Diagnosis and management of secondary causes of steatohepatitis. J Hepatol 2021;74:1455-71. [PMID: 33577920 DOI: 10.1016/j.jhep.2021.01.045] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
97 Villoria JG, Pajares S, López RM, Marin JL, Ribes A. Neonatal Screening for Inherited Metabolic Diseases in 2016. Seminars in Pediatric Neurology 2016;23:257-72. [DOI: 10.1016/j.spen.2016.11.001] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 3.2] [Reference Citation Analysis]
98 Krijt J, Sokolová J, Ješina P, Dvořáková L, Řeboun M, Brennerová K, Mistrík M, Zeman J, Honzík T, Kožich V. Activity of the liver enzyme ornithine carbamoyltransferase (OTC) in blood: LC-MS/MS assay for non-invasive diagnosis of ornithine carbamoyltransferase deficiency. Clinical Chemistry and Laboratory Medicine (CCLM) 2017;55:1168-77. [DOI: 10.1515/cclm-2016-0715] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
99 Kato H, Kawaguchi K, Sawa T. Anesthetic management of a pediatric patient with arginase-1 deficiency undergoing strabismus operation: a case report. JA Clin Rep 2019;5:56. [PMID: 32025996 DOI: 10.1186/s40981-019-0274-6] [Reference Citation Analysis]
100 Magner M, Dvorakova V, Tesarova M, Mazurova S, Hansikova H, Zahorec M, Brennerova K, Bzduch V, Spiegel R, Horovitz Y, Mandel H, Eminoğlu FT, Mayr JA, Koch J, Martinelli D, Bertini E, Konstantopoulou V, Smet J, Rahman S, Broomfield A, Stojanović V, Dionisi-vici C, van Coster R, Morava-kozicz E, Sperl W, Zeman J, Honzik T. TMEM70 deficiency: long-term outcome of 48 patients. J Inherit Metab Dis 2015;38:417-26. [DOI: 10.1007/s10545-014-9774-8] [Cited by in Crossref: 40] [Cited by in F6Publishing: 32] [Article Influence: 5.0] [Reference Citation Analysis]
101 Kido J, Matsumoto S, Häberle J, Nakajima Y, Wada Y, Mochizuki N, Murayama K, Lee T, Mochizuki H, Watanabe Y, Horikawa R, Kasahara M, Nakamura K. Long-term outcome of urea cycle disorders: Report from a nationwide study in Japan. J Inherit Metab Dis 2021;44:826-37. [PMID: 33840128 DOI: 10.1002/jimd.12384] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
102 Squires RH, Ng V, Romero R, Ekong U, Hardikar W, Emre S, Mazariegos GV. Evaluation of the pediatric patient for liver transplantation: 2014 practice guideline by the American Association for the Study of Liver Diseases, American Society of Transplantation and the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition. Hepatology. 2014;60:362-398. [PMID: 24782219 DOI: 10.1002/hep.27191] [Cited by in Crossref: 101] [Cited by in F6Publishing: 77] [Article Influence: 12.6] [Reference Citation Analysis]
103 Kido J, Matsumoto S, Häberle J, Inomata Y, Kasahara M, Sakamoto S, Horikawa R, Tanemura A, Okajima H, Suzuki T, Nakamura K. Role of liver transplantation in urea cycle disorders: Report from a nationwide study in Japan. J Inherit Metab Dis 2021. [PMID: 34232532 DOI: 10.1002/jimd.12415] [Reference Citation Analysis]
104 Alfadhel M, Mutairi FA, Makhseed N, Jasmi FA, Al-Thihli K, Al-Jishi E, AlSayed M, Al-Hassnan ZN, Al-Murshedi F, Häberle J, Ben-Omran T. Guidelines for acute management of hyperammonemia in the Middle East region. Ther Clin Risk Manag 2016;12:479-87. [PMID: 27099506 DOI: 10.2147/TCRM.S93144] [Cited by in Crossref: 18] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
105 Hediger N, Landolt MA, Diez-fernandez C, Huemer M, Häberle J. The impact of ammonia levels and dialysis on outcome in 202 patients with neonatal onset urea cycle disorders. J Inherit Metab Dis 2018;41:689-98. [DOI: 10.1007/s10545-018-0157-4] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
106 AlTassan R, Bubshait D, Imtiaz F, Rahbeeni Z. A retrospective biochemical, molecular, and neurocognitive review of Saudi patients with argininosuccinic aciduria. Eur J Med Genet 2018;61:307-11. [PMID: 29326055 DOI: 10.1016/j.ejmg.2018.01.007] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
107 Coutelier M, Goizet C, Durr A, Habarou F, Morais S, Dionne-Laporte A, Tao F, Konop J, Stoll M, Charles P, Jacoupy M, Matusiak R, Alonso I, Tallaksen C, Mairey M, Kennerson M, Gaussen M, Schule R, Janin M, Morice-Picard F, Durand CM, Depienne C, Calvas P, Coutinho P, Saudubray JM, Rouleau G, Brice A, Nicholson G, Darios F, Loureiro JL, Zuchner S, Ottolenghi C, Mochel F, Stevanin G. Alteration of ornithine metabolism leads to dominant and recessive hereditary spastic paraplegia. Brain 2015;138:2191-205. [PMID: 26026163 DOI: 10.1093/brain/awv143] [Cited by in Crossref: 53] [Cited by in F6Publishing: 45] [Article Influence: 7.6] [Reference Citation Analysis]
108 Opladen T, Lindner M, Das AM, Marquardt T, Khan A, Emre SH, Burton BK, Barshop BA, Böhm T, Meyburg J, Zangerl K, Mayorandan S, Burgard P, Dürr UH, Rosenkranz B, Rennecke J, Derbinski J, Yudkoff M, Hoffmann GF. In vivo monitoring of urea cycle activity with (13)C-acetate as a tracer of ureagenesis. Mol Genet Metab 2016;117:19-26. [PMID: 26597322 DOI: 10.1016/j.ymgme.2015.11.007] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
109 Lin Y, Gao H, Lu B, Zhou S, Zheng T, Lin W, Zhu L, Jiang M, Fu Q. Citrullinemia type I is associated with a novel splicing variant, c.773 + 4A > C, in ASS1: a case report and literature review. BMC Med Genet 2019;20:110. [PMID: 31208364 DOI: 10.1186/s12881-019-0836-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
110 Baumgartner MR, Hörster F, Dionisi-Vici C, Haliloglu G, Karall D, Chapman KA, Huemer M, Hochuli M, Assoun M, Ballhausen D, Burlina A, Fowler B, Grünert SC, Grünewald S, Honzik T, Merinero B, Pérez-Cerdá C, Scholl-Bürgi S, Skovby F, Wijburg F, MacDonald A, Martinelli D, Sass JO, Valayannopoulos V, Chakrapani A. Proposed guidelines for the diagnosis and management of methylmalonic and propionic acidemia. Orphanet J Rare Dis 2014;9:130. [PMID: 25205257 DOI: 10.1186/s13023-014-0130-8] [Cited by in Crossref: 287] [Cited by in F6Publishing: 247] [Article Influence: 35.9] [Reference Citation Analysis]
111 Galsgaard KD, Pedersen J, Kjeldsen SAS, Winther-Sørensen M, Stojanovska E, Vilstrup H, Ørskov C, Wewer Albrechtsen NJ, Holst JJ. Glucagon receptor signaling is not required for N-carbamoyl glutamate- and l-citrulline-induced ureagenesis in mice. Am J Physiol Gastrointest Liver Physiol 2020;318:G912-27. [PMID: 32174131 DOI: 10.1152/ajpgi.00294.2019] [Reference Citation Analysis]
112 Vorrink SU, Ullah S, Schmidt S, Nandania J, Velagapudi V, Beck O, Ingelman-Sundberg M, Lauschke VM. Endogenous and xenobiotic metabolic stability of primary human hepatocytes in long-term 3D spheroid cultures revealed by a combination of targeted and untargeted metabolomics. FASEB J 2017;31:2696-708. [PMID: 28264975 DOI: 10.1096/fj.201601375R] [Cited by in Crossref: 75] [Cited by in F6Publishing: 36] [Article Influence: 15.0] [Reference Citation Analysis]
113 Yap S, Gougeard N, Hart AR, Barcelona B, Rubio V. N-carbamoylglutamate-responsive carbamoyl phosphate synthetase 1 (CPS1) deficiency: A patient with a novel CPS1 mutation and an experimental study on the mutation's effects. JIMD Rep 2019;48:36-44. [PMID: 31392111 DOI: 10.1002/jmd2.12034] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
114 Parmeggiani B, Vargas CR. Oxidative stress in urea cycle disorders: Findings from clinical and basic research. Clinica Chimica Acta 2018;477:121-6. [DOI: 10.1016/j.cca.2017.11.041] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
115 Baruteau J, Diez-Fernandez C, Lerner S, Ranucci G, Gissen P, Dionisi-Vici C, Nagamani S, Erez A, Häberle J. Argininosuccinic aciduria: Recent pathophysiological insights and therapeutic prospects. J Inherit Metab Dis 2019;42:1147-61. [PMID: 30723942 DOI: 10.1002/jimd.12047] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 6.0] [Reference Citation Analysis]
116 Sirrs S, Hannah-shmouni F, Nantel S, Neuberger J, Yoshida EM. Transplantation as disease modifying therapy in adults with inherited metabolic disorders. J Inherit Metab Dis 2018;41:885-96. [DOI: 10.1007/s10545-018-0141-z] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
117 Häberle J, Rubio V. Hyperammonemias and Related Disorders. In: Blau N, Duran M, Gibson KM, Dionisi Vici C, editors. Physician's Guide to the Diagnosis, Treatment, and Follow-Up of Inherited Metabolic Diseases. Berlin: Springer Berlin Heidelberg; 2014. pp. 47-62. [DOI: 10.1007/978-3-642-40337-8_4] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
118 Vitoria I, Dalmau J, Ribes C, Rausell D, García AM, López-Montiel J, Rubio V. Citrin deficiency in a Romanian child living in Spain highlights the worldwide distribution of this defect and illustrates the value of nutritional therapy. Mol Genet Metab 2013;110:181-3. [PMID: 23835251 DOI: 10.1016/j.ymgme.2013.06.011] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
119 Manta-Vogli PD, Schulpis KH, Dotsikas Y, Loukas YL. Nutrition and medical support during pregnancy and lactation in women with inborn errors of intermediary metabolism disorders (IEMDs). J Pediatr Endocrinol Metab 2020;33:5-20. [PMID: 31804959 DOI: 10.1515/jpem-2019-0048] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
120 Haschke-becher E, Kainz A, Bachmann C. Reference values of amino acids and of common clinical chemistry in plasma of healthy infants aged 1 and 4 months. J Inherit Metab Dis 2016;39:25-37. [DOI: 10.1007/s10545-015-9870-4] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.9] [Reference Citation Analysis]
121 Chapel-Crespo CC, Diaz GA, Oishi K. Efficacy of N-carbamoyl-L-glutamic acid for the treatment of inherited metabolic disorders. Expert Rev Endocrinol Metab 2016;11:467-73. [PMID: 30034506 DOI: 10.1080/17446651.2016.1239526] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
122 Kang H, Kim M, Lee JH. Nutritional Management in a Patient with Citrullinemia Type 1. Clin Nutr Res 2021;10:268-77. [PMID: 34386445 DOI: 10.7762/cnr.2021.10.3.268] [Reference Citation Analysis]
123 Mulroy E, Baschieri F, Magrinelli F, Latorre A, Cortelli P, Bhatia KP. Movement Disorders and Liver Disease. Mov Disord Clin Pract 2021;8:828-42. [PMID: 34401403 DOI: 10.1002/mdc3.13238] [Reference Citation Analysis]
124 Squires JE. When Considering Liver Transplant for Children with Glycogen Storage Disease 1b. Liver Transpl 2019;26:12-3. [DOI: 10.1002/lt.25688] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
125 Diez-fernandez C, Rüfenacht V, Häberle J. Mutations in the Human Argininosuccinate Synthetase ( ASS1 ) Gene, Impact on Patients, Common Changes, and Structural Considerations: HUMAN MUTATION. Human Mutation 2017;38:471-84. [DOI: 10.1002/humu.23184] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 4.0] [Reference Citation Analysis]
126 Vasquez-Loarte T, Thompson JD, Merritt JL 2nd. Considering Proximal Urea Cycle Disorders in Expanded Newborn Screening. Int J Neonatal Screen 2020;6:E77. [PMID: 33124615 DOI: 10.3390/ijns6040077] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
127 Kurtz CB, Millet YA, Puurunen MK, Perreault M, Charbonneau MR, Isabella VM, Kotula JW, Antipov E, Dagon Y, Denney WS, Wagner DA, West KA, Degar AJ, Brennan AM, Miller PF. An engineered E. coli Nissle improves hyperammonemia and survival in mice and shows dose-dependent exposure in healthy humans. Sci Transl Med 2019;11:eaau7975. [PMID: 30651324 DOI: 10.1126/scitranslmed.aau7975] [Cited by in Crossref: 91] [Cited by in F6Publishing: 78] [Article Influence: 45.5] [Reference Citation Analysis]
128 Silvera-Ruiz SM, Arranz JA, Häberle J, Angaroni CJ, Bezard M, Guelbert N, Becerra A, Peralta F, de Kremer RD, Laróvere LE. Urea cycle disorders in Argentine patients: clinical presentation, biochemical and genetic findings. Orphanet J Rare Dis 2019;14:203. [PMID: 31426867 DOI: 10.1186/s13023-019-1177-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
129 Yu L, Rayhill S, Hsu E, Landis C. Liver Transplantation for Urea Cycle Disorders: Analysis of the United Network for Organ Sharing Database. Transplantation Proceedings 2015;47:2413-8. [DOI: 10.1016/j.transproceed.2015.09.020] [Cited by in Crossref: 28] [Cited by in F6Publishing: 17] [Article Influence: 4.0] [Reference Citation Analysis]
130 Häberle J, Huemer M. Evaluation of Implementation, Adaptation and Use of the Recently Proposed Urea Cycle Disorders Guidelines. JIMD Rep 2015;21:65-70. [PMID: 25690729 DOI: 10.1007/8904_2014_387] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
131 De Las Heras J, Aldámiz-Echevarría L, Martínez-Chantar ML, Delgado TC. An update on the use of benzoate, phenylacetate and phenylbutyrate ammonia scavengers for interrogating and modifying liver nitrogen metabolism and its implications in urea cycle disorders and liver disease. Expert Opin Drug Metab Toxicol 2017;13:439-48. [PMID: 27860485 DOI: 10.1080/17425255.2017.1262843] [Cited by in Crossref: 23] [Cited by in F6Publishing: 17] [Article Influence: 3.8] [Reference Citation Analysis]
132 Laemmle A, Stricker T, Häberle J. Switch from Sodium Phenylbutyrate to Glycerol Phenylbutyrate Improved Metabolic Stability in an Adolescent with Ornithine Transcarbamylase Deficiency. JIMD Rep 2017;31:11-4. [PMID: 27000017 DOI: 10.1007/8904_2016_551] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
133 Liu NY, Cay-Durgun P, Lai T, Sprowls M, Thomas L, Lind ML, Forzani E. A Handheld, Colorimetric Optoelectronic Dynamics Analyzer for Measuring Total Ammonia of Biological Samples. IEEE J Transl Eng Health Med 2018;6:2800610. [PMID: 30112251 DOI: 10.1109/JTEHM.2018.2840678] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
134 Bijarnia-Mahay S, Häberle J, Jalan AB, Puri RD, Kohli S, Kudalkar K, Rüfenacht V, Gupta D, Maurya D, Verma J, Shigematsu Y, Yamaguchi S, Saxena R, Verma IC. Urea cycle disorders in India: clinical course, biochemical and genetic investigations, and prenatal testing. Orphanet J Rare Dis 2018;13:174. [PMID: 30285816 DOI: 10.1186/s13023-018-0908-1] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 3.5] [Reference Citation Analysis]
135 Diez-Fernandez C, Wellauer O, Gemperle C, Rüfenacht V, Fingerhut R, Häberle J. Kinetic mutations in argininosuccinate synthetase deficiency: characterisation and in vitro correction by substrate supplementation. J Med Genet 2016;53:710-9. [PMID: 27287393 DOI: 10.1136/jmedgenet-2016-103937] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
136 Laemmle A, Gallagher RC, Keogh A, Stricker T, Gautschi M, Nuoffer JM, Baumgartner MR, Häberle J. Frequency and Pathophysiology of Acute Liver Failure in Ornithine Transcarbamylase Deficiency (OTCD). PLoS One 2016;11:e0153358. [PMID: 27070778 DOI: 10.1371/journal.pone.0153358] [Cited by in Crossref: 28] [Cited by in F6Publishing: 23] [Article Influence: 4.7] [Reference Citation Analysis]
137 Baruteau J, Waddington SN, Alexander IE, Gissen P. Gene therapy for monogenic liver diseases: clinical successes, current challenges and future prospects. J Inherit Metab Dis 2017;40:497-517. [PMID: 28567541 DOI: 10.1007/s10545-017-0053-3] [Cited by in Crossref: 45] [Cited by in F6Publishing: 45] [Article Influence: 9.0] [Reference Citation Analysis]
138 Torkzaban M, Haddad A, Baxter JK, Berghella V, Gahl WA, Al-Kouatly HB. Maternal ornithine transcarbamylase deficiency, a genetic condition associated with high maternal and neonatal mortality every clinician should know: A systematic review. Am J Med Genet A 2019;179:2091-100. [PMID: 31441224 DOI: 10.1002/ajmg.a.61329] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
139 Bigot A, Tchan MC, Thoreau B, Blasco H, Maillot F. Liver involvement in urea cycle disorders: a review of the literature. J Inherit Metab Dis. 2017;40:757-769. [PMID: 28900784 DOI: 10.1007/s10545-017-0088-5] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 4.6] [Reference Citation Analysis]
140 Chen C, Bain KB, Iuppa JA, Yusen RD, Byers DE, Patterson GA, Trulock EP, Hachem RR, Witt CA. Hyperammonemia Syndrome After Lung Transplantation: A Single Center Experience. Transplantation. 2016;100:678-684. [PMID: 26335916 DOI: 10.1097/tp.0000000000000868] [Cited by in Crossref: 34] [Cited by in F6Publishing: 14] [Article Influence: 5.7] [Reference Citation Analysis]
141 Adam S, Almeida MF, Assoun M, Baruteau J, Bernabei SM, Bigot S, Champion H, Daly A, Dassy M, Dawson S, Dixon M, Dokoupil K, Dubois S, Dunlop C, Evans S, Eyskens F, Faria A, Favre E, Ferguson C, Goncalves C, Gribben J, Heddrich-Ellerbrok M, Jankowski C, Janssen-Regelink R, Jouault C, Laguerre C, Le Verge S, Link R, Lowry S, Luyten K, Macdonald A, Maritz C, McDowell S, Meyer U, Micciche A, Robert M, Robertson LV, Rocha JC, Rohde C, Saruggia I, Sjoqvist E, Stafford J, Terry A, Thom R, Vande Kerckhove K, van Rijn M, van Teeffelen-Heithoff A, Wegberg Av, van Wyk K, Vasconcelos C, Vestergaard H, Webster D, White FJ, Wildgoose J, Zweers H. Dietary management of urea cycle disorders: European practice. Mol Genet Metab 2013;110:439-45. [PMID: 24113687 DOI: 10.1016/j.ymgme.2013.09.003] [Cited by in Crossref: 28] [Cited by in F6Publishing: 23] [Article Influence: 3.1] [Reference Citation Analysis]
142 Kardos J, Héja L, Jemnitz K, Kovács R, Palkovits M. The nature of early astroglial protection-Fast activation and signaling. Prog Neurobiol 2017;153:86-99. [PMID: 28342942 DOI: 10.1016/j.pneurobio.2017.03.005] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
143 Panza E, Martinelli D, Magini P, Dionisi Vici C, Seri M. Hereditary Spastic Paraplegia Is a Common Phenotypic Finding in ARG1 Deficiency, P5CS Deficiency and HHH Syndrome: Three Inborn Errors of Metabolism Caused by Alteration of an Interconnected Pathway of Glutamate and Urea Cycle Metabolism. Front Neurol 2019;10:131. [PMID: 30853934 DOI: 10.3389/fneur.2019.00131] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
144 Häberle J. Clinical and biochemical aspects of primary and secondary hyperammonemic disorders. Arch Biochem Biophys. 2013;536:101-108. [PMID: 23628343 DOI: 10.1016/j.abb.2013.04.009] [Cited by in Crossref: 57] [Cited by in F6Publishing: 47] [Article Influence: 6.3] [Reference Citation Analysis]
145 Sen K, Anderson AA, Whitehead MT, Gropman AL. Review of Multi-Modal Imaging in Urea Cycle Disorders: The Old, the New, the Borrowed, and the Blue. Front Neurol 2021;12:632307. [PMID: 33995244 DOI: 10.3389/fneur.2021.632307] [Reference Citation Analysis]
146 Kido J, Matsumoto S, Ito T, Hirose S, Fukui K, Kojima-Ishii K, Mushimoto Y, Yoshida S, Ishige M, Sakai N, Nakamura K. Physical, cognitive, and social status of patients with urea cycle disorders in Japan. Mol Genet Metab Rep 2021;27:100724. [PMID: 33614409 DOI: 10.1016/j.ymgmr.2021.100724] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
147 Molina Gutiérrez M, López López R, Morais López A, Bueno Barriocanal M, Martínez Ojinaga Nodal E, Alcolea Sánchez A, García García S. Inherited metabolic disorders in pediatric emergency services. Anales de Pediatría (English Edition) 2015;82:404-11. [DOI: 10.1016/j.anpede.2015.05.016] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
148 Bonnot O, Klünemann HH, Sedel F, Tordjman S, Cohen D, Walterfang M. Diagnostic and treatment implications of psychosis secondary to treatable metabolic disorders in adults: a systematic review. Orphanet J Rare Dis 2014;9:65. [PMID: 24775716 DOI: 10.1186/1750-1172-9-65] [Cited by in Crossref: 56] [Cited by in F6Publishing: 34] [Article Influence: 7.0] [Reference Citation Analysis]
149 Colonetti K, Roesch LF, Schwartz IVD. The microbiome and inborn errors of metabolism: Why we should look carefully at their interplay? Genet Mol Biol 2018;41:515-32. [PMID: 30235399 DOI: 10.1590/1678-4685-GMB-2017-0235] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
150 Chakrapani A, Valayannopoulos V, Segarra NG, Del Toro M, Donati MA, García-Cazorla A, González MJ, Plisson C, Giordano V. Effect of carglumic acid with or without ammonia scavengers on hyperammonaemia in acute decompensation episodes of organic acidurias. Orphanet J Rare Dis 2018;13:97. [PMID: 29925411 DOI: 10.1186/s13023-018-0840-4] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
151 Schlune A, vom Dahl S, Häussinger D, Ensenauer R, Mayatepek E. Hyperargininemia due to arginase I deficiency: the original patients and their natural history, and a review of the literature. Amino Acids 2015;47:1751-62. [DOI: 10.1007/s00726-015-2032-z] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 3.9] [Reference Citation Analysis]
152 De Sabbata G, Boisgerault F, Guarnaccia C, Iaconcig A, Bortolussi G, Collaud F, Ronzitti G, Sola MS, Vidal P, Rouillon J, Charles S, Nicastro E, D'Antiga L, Ilyinskii P, Mingozzi F, Kishimoto TK, Muro AF. Long-term correction of ornithine transcarbamylase deficiency in Spf-Ash mice with a translationally optimized AAV vector. Mol Ther Methods Clin Dev 2021;20:169-80. [PMID: 33473356 DOI: 10.1016/j.omtm.2020.11.005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
153 van Spronsen FJ, van Wegberg AM, Ahring K, Bélanger-Quintana A, Blau N, Bosch AM, Burlina A, Campistol J, Feillet F, Giżewska M, Huijbregts SC, Kearney S, Leuzzi V, Maillot F, Muntau AC, Trefz FK, van Rijn M, Walter JH, MacDonald A. Key European guidelines for the diagnosis and management of patients with phenylketonuria. Lancet Diabetes Endocrinol 2017;5:743-56. [PMID: 28082082 DOI: 10.1016/S2213-8587(16)30320-5] [Cited by in Crossref: 150] [Cited by in F6Publishing: 79] [Article Influence: 30.0] [Reference Citation Analysis]
154 Sousa C, Almeida MF, Sousa Barbosa C, Martins E, Janeiro P, Tavares de Almeida I, Macdonald A, Rocha JC. The European Phenylketonuria Guidelines and the challenges on management practices in Portugal. Journal of Pediatric Endocrinology and Metabolism 2019;32:623-9. [DOI: 10.1515/jpem-2018-0527] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
155 Tarasenko TN, Singh LN, Chatterji-Len M, Zerfas PM, Cusmano-Ozog K, McGuire PJ. Kupffer cells modulate hepatic fatty acid oxidation during infection with PR8 influenza. Biochim Biophys Acta 2015;1852:2391-401. [PMID: 26319418 DOI: 10.1016/j.bbadis.2015.08.021] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
156 Liu J, Lkhagva E, Chung HJ, Kim HJ, Hong ST. The Pharmabiotic Approach to Treat Hyperammonemia. Nutrients 2018;10:E140. [PMID: 29382084 DOI: 10.3390/nu10020140] [Cited by in Crossref: 33] [Cited by in F6Publishing: 27] [Article Influence: 8.3] [Reference Citation Analysis]
157 Pham TS, Reda A, Ngan Nguyen TT, Ng SJ, Huan VT, Viet DC, Huy NT. Blood exchange transfusion in viral hepatitis in a small infant: a case report. Transfus Apher Sci 2020;59:102907. [PMID: 32883595 DOI: 10.1016/j.transci.2020.102907] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
158 Ahrens-Nicklas RC, Slap G, Ficicioglu C. Adolescent presentations of inborn errors of metabolism. J Adolesc Health 2015;56:477-82. [PMID: 25907648 DOI: 10.1016/j.jadohealth.2015.01.008] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
159 Sakhr HM, Hassan MH, Desoky T. Possible Associations of Disturbed Neurometals and Ammonia with Glycaemic Control in Type 1 Diabetic Children with Attention Deficit Hyperactivity Disorder. Biol Trace Elem Res 2020;198:68-76. [PMID: 32020524 DOI: 10.1007/s12011-020-02063-5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
160 Savy N, Brossier D, Brunel-Guitton C, Ducharme-Crevier L, Du Pont-Thibodeau G, Jouvet P. Acute pediatric hyperammonemia: current diagnosis and management strategies. Hepat Med 2018;10:105-15. [PMID: 30254497 DOI: 10.2147/HMER.S140711] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
161 Toquet S, Spodenkiewicz M, Douillard C, Maillot F, Arnoux JB, Damaj L, Odent S, Moreau C, Redonnet-Vernhet I, Mesli S, Servais A, Noel E, Charriere S, Rigalleau V, Lavigne C, Kaphan E, Roubertie A, Besson G, Bigot A, Servettaz A, Mochel F, Garnotel R. Adult-onset diagnosis of urea cycle disorders: Results of a French cohort of 71 patients. J Inherit Metab Dis 2021;44:1199-214. [PMID: 34014557 DOI: 10.1002/jimd.12403] [Reference Citation Analysis]
162 Häberle J, Chakrapani A, Ah Mew N, Longo N. Hyperammonaemia in classic organic acidaemias: a review of the literature and two case histories. Orphanet J Rare Dis 2018;13:219. [PMID: 30522498 DOI: 10.1186/s13023-018-0963-7] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
163 Hook D, Diaz GA, Lee B, Bartley J, Longo N, Berquist W, Le Mons C, Rudolph-Angelich I, Porter M, Scharschmidt BF, Mokhtarani M. Protein and calorie intakes in adult and pediatric subjects with urea cycle disorders participating in clinical trials of glycerol phenylbutyrate. Mol Genet Metab Rep 2016;6:34-40. [PMID: 27014577 DOI: 10.1016/j.ymgmr.2015.11.002] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
164 Berry SA, Longo N, Diaz GA, Mccandless SE, Smith WE, Harding CO, Zori R, Ficicioglu C, Lichter-konecki U, Robinson B, Vockley J. Safety and efficacy of glycerol phenylbutyrate for management of urea cycle disorders in patients aged 2 months to 2 years. Molecular Genetics and Metabolism 2017;122:46-53. [DOI: 10.1016/j.ymgme.2017.09.002] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
165 Diez-fernandez C, Rüfenacht V, Gemperle C, Fingerhut R, Häberle J. Mutations and common variants in the human arginase 1 ( ARG1 ) gene: Impact on patients, diagnostics, and protein structure considerations. Human Mutation 2018;39:1029-50. [DOI: 10.1002/humu.23545] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
166 Kok CY, Cunningham SC, Kuchel PW, Alexander IE. Insights into Gene Therapy for Urea Cycle Defects by Mathematical Modeling. Hum Gene Ther 2019;30:1385-94. [PMID: 31215258 DOI: 10.1089/hum.2019.053] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
167 Anstey JR, Haydon TP, Ghanpur RB, de Jong G. Initial presentation of a urea cycle disorder in adulthood: an under-recognised cause of severe neurological dysfunction. Med J Aust 2015;203:445-7. [PMID: 26654615 DOI: 10.5694/mja15.00510] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
168 Matsumoto S, Häberle J, Kido J, Mitsubuchi H, Endo F, Nakamura K. Urea cycle disorders-update. J Hum Genet 2019;64:833-47. [PMID: 31110235 DOI: 10.1038/s10038-019-0614-4] [Cited by in Crossref: 31] [Cited by in F6Publishing: 25] [Article Influence: 10.3] [Reference Citation Analysis]
169 Mukhtar A, Dabbous H, El Sayed R, Aboulfetouh F, Bahaa M, Abdelaal A, Fathy M, El-meteini M. A Novel Mutation of the Ornithine Transcarbamylase Gene Leading to Fatal Hyperammonemia in a Liver Transplant Recipient: Adult LDLT From Asymptomatic Donor with OTCD. American Journal of Transplantation 2013;13:1084-7. [DOI: 10.1111/ajt.12146] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
170 Zielonka M, Probst J, Carl M, Hoffmann GF, Kölker S, Okun JG. Bioenergetic dysfunction in a zebrafish model of acute hyperammonemic decompensation. Exp Neurol 2019;314:91-9. [PMID: 30653968 DOI: 10.1016/j.expneurol.2019.01.008] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
171 Häberle J, Rubio V. Disorders of the Urea Cycle and Related Enzymes. In: Saudubray J, Baumgartner MR, Walter J, editors. Inborn Metabolic Diseases. Berlin: Springer Berlin Heidelberg; 2016. pp. 295-308. [DOI: 10.1007/978-3-662-49771-5_19] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
172 Maines E, Di Palma A, Burlina A. Food triggers and inherited metabolic disorders: a challenge to the pediatrician. Ital J Pediatr 2018;44:18. [PMID: 29368648 DOI: 10.1186/s13052-018-0456-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
173 Nakamura K, Kido J, Matsumoto S, Mitsubuchi H, Endo F. Clinical manifestations and growth of patients with urea cycle disorders in Japan. J Hum Genet 2016;61:613-6. [DOI: 10.1038/jhg.2016.17] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
174 Peng M, Cai Y, Shao Y, Zhao L, Jiang M, Lin Y, Yin X, Sheng H, Liu L. Simultaneous quantification of 48 plasma amino acids by liquid chromatography-tandem mass spectrometry to investigate urea cycle disorders. Clinica Chimica Acta 2019;495:406-16. [DOI: 10.1016/j.cca.2019.05.011] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
175 Peña-Quintana L, Llarena M, Reyes-Suárez D, Aldámiz-Echevarria L. Profile of sodium phenylbutyrate granules for the treatment of urea-cycle disorders: patient perspectives. Patient Prefer Adherence 2017;11:1489-96. [PMID: 28919721 DOI: 10.2147/PPA.S136754] [Cited by in Crossref: 13] [Cited by in F6Publishing: 5] [Article Influence: 2.6] [Reference Citation Analysis]
176 Martín-Hernández E, Aldámiz-Echevarría L, Castejón-Ponce E, Pedrón-Giner C, Couce ML, Serrano-Nieto J, Pintos-Morell G, Bélanger-Quintana A, Martínez-Pardo M, García-Silva MT, Quijada-Fraile P, Vitoria-Miñana I, Dalmau J, Lama-More RA, Bueno-Delgado MA, Del Toro-Riera M, García-Jiménez I, Sierra-Córcoles C, Ruiz-Pons M, Peña-Quintana LJ, Vives-Piñera I, Moráis A, Balmaseda-Serrano E, Meavilla S, Sanjurjo-Crespo P, Pérez-Cerdá C. Urea cycle disorders in Spain: an observational, cross-sectional and multicentric study of 104 cases. Orphanet J Rare Dis 2014;9:187. [PMID: 25433810 DOI: 10.1186/s13023-014-0187-4] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 3.0] [Reference Citation Analysis]
177 Marquetand J, Freisinger P, Lindig T, Euler S, Gasser M, Overkamp D. Ammonia and coma - a case report of late onset hemizygous ornithine carbamyltransferase deficiency in 68-year-old female. BMC Neurol 2020;20:118. [PMID: 32252669 DOI: 10.1186/s12883-020-01700-9] [Reference Citation Analysis]
178 Nozaki F, Kusunoki T, Okamoto N, Yamamoto Y, Miya F, Tsunoda T, Kosaki K, Kumada T, Shibata M, Fujii T. ALDH18A1-related cutis laxa syndrome with cyclic vomiting. Brain Dev 2016;38:678-84. [PMID: 26829900 DOI: 10.1016/j.braindev.2016.01.003] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
179 Andrade F, Vitoria I, Martín Hernández E, Pintos-Morell G, Correcher P, Puig-Piña R, Quijada-Fraile P, Peña-Quintana L, Marquez AM, Villate O, García Silva MT, de Las Heras J, Ceberio L, Rodrigues E, Almeida Campos T, Yahyaoui R, Blasco J, Vives-Piñera I, Gil D, Del Toro M, Ruiz-Pons M, Cañedo E, Barba Romero MA, García-Jiménez MC, Aldámiz-Echevarría L. Quantification of urinary derivatives of Phenylbutyric and Benzoic acids by LC-MS/MS as treatment compliance biomarkers in Urea Cycle disorders. J Pharm Biomed Anal 2019;176:112798. [PMID: 31394303 DOI: 10.1016/j.jpba.2019.112798] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
180 Husson MC, Schiff M, Fouilhoux A, Cano A, Dobbelaere D, Brassier A, Mention K, Arnoux JB, Feillet F, Chabrol B, Guffon N, Elie C, de Lonlay P. Efficacy and safety of i.v. sodium benzoate in urea cycle disorders: a multicentre retrospective study. Orphanet J Rare Dis 2016;11:127. [PMID: 27663197 DOI: 10.1186/s13023-016-0513-0] [Cited by in Crossref: 20] [Cited by in F6Publishing: 14] [Article Influence: 3.3] [Reference Citation Analysis]
181 Kölker S, Cazorla AG, Valayannopoulos V, Lund AM, Burlina AB, Sykut-cegielska J, Wijburg FA, Teles EL, Zeman J, Dionisi-vici C, Barić I, Karall D, Augoustides-savvopoulou P, Aksglaede L, Arnoux J, Avram P, Baumgartner MR, Blasco-alonso J, Chabrol B, Chakrapani A, Chapman K, i Saladelafont EC, Couce ML, de Meirleir L, Dobbelaere D, Dvorakova V, Furlan F, Gleich F, Gradowska W, Grünewald S, Jalan A, Häberle J, Haege G, Lachmann R, Laemmle A, Langereis E, de Lonlay P, Martinelli D, Matsumoto S, Mühlhausen C, de Baulny HO, Ortez C, Peña-quintana L, Ramadža DP, Rodrigues E, Scholl-bürgi S, Sokal E, Staufner C, Summar ML, Thompson N, Vara R, Pinera IV, Walter JH, Williams M, Burgard P. The phenotypic spectrum of organic acidurias and urea cycle disorders. Part 1: the initial presentation. J Inherit Metab Dis 2015;38:1041-57. [DOI: 10.1007/s10545-015-9839-3] [Cited by in Crossref: 118] [Cited by in F6Publishing: 105] [Article Influence: 16.9] [Reference Citation Analysis]
182 Al Kaabi EH, El-Hattab AW. N-acetylglutamate synthase deficiency: Novel mutation associated with neonatal presentation and literature review of molecular and phenotypic spectra. Mol Genet Metab Rep 2016;8:94-8. [PMID: 27570737 DOI: 10.1016/j.ymgmr.2016.08.004] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.7] [Reference Citation Analysis]
183 Dionisi-Vici C, Diodato D, Torre G, Picca S, Pariante R, Giuseppe Picardo S, Di Meo I, Rizzo C, Tiranti V, Zeviani M, De Ville De Goyet J. Liver transplant in ethylmalonic encephalopathy: a new treatment for an otherwise fatal disease. Brain. 2016;139:1045-1051. [PMID: 26917598 DOI: 10.1093/brain/aww013] [Cited by in Crossref: 49] [Cited by in F6Publishing: 38] [Article Influence: 8.2] [Reference Citation Analysis]
184 Nettesheim S, Kölker S, Karall D, Häberle J, Posset R, Hoffmann GF, Heinrich B, Gleich F, Garbade SF; Arbeitsgemeinschaft für Pädiatrische Stoffwechselstörungen (APS); European registry and network for Intoxication type Metabolic Diseases (E-IMD); Erhebungseinheit für Seltene Pädiatrische Erkrankungen in Deutschland (ESPED); Austrian Metabolic Group; Swiss Paediatric Surveillance Unit (SPSU). Incidence, disease onset and short-term outcome in urea cycle disorders -cross-border surveillance in Germany, Austria and Switzerland. Orphanet J Rare Dis 2017;12:111. [PMID: 28619060 DOI: 10.1186/s13023-017-0661-x] [Cited by in Crossref: 29] [Cited by in F6Publishing: 25] [Article Influence: 5.8] [Reference Citation Analysis]
185 Allegri G, Deplazes S, Grisch-Chan HM, Mathis D, Fingerhut R, Häberle J, Thöny B. A simple dried blood spot-method for in vivo measurement of ureagenesis by gas chromatography-mass spectrometry using stable isotopes. Clin Chim Acta 2017;464:236-43. [PMID: 27923571 DOI: 10.1016/j.cca.2016.11.038] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
186 Allegri G, Deplazes S, Rimann N, Causton B, Scherer T, Leff JW, Diez-Fernandez C, Klimovskaia A, Fingerhut R, Krijt J, Kožich V, Nuoffer JM, Grisch-Chan HM, Thöny B, Häberle J. Comprehensive characterization of ureagenesis in the spfash mouse, a model of human ornithine transcarbamylase deficiency, reveals age-dependency of ammonia detoxification. J Inherit Metab Dis 2019;42:1064-76. [PMID: 30714172 DOI: 10.1002/jimd.12068] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
187 Ferreira CR, van Karnebeek CDM. Inborn errors of metabolism. Handb Clin Neurol 2019;162:449-81. [PMID: 31324325 DOI: 10.1016/B978-0-444-64029-1.00022-9] [Cited by in Crossref: 17] [Cited by in F6Publishing: 8] [Article Influence: 8.5] [Reference Citation Analysis]
188 Matoori S, Forster V, Agostoni V, Bettschart-Wolfensberger R, Bektas RN, Thöny B, Häberle J, Leroux JC, Kabbaj M. Preclinical evaluation of liposome-supported peritoneal dialysis for the treatment of hyperammonemic crises. J Control Release 2020;328:503-13. [PMID: 32860926 DOI: 10.1016/j.jconrel.2020.08.040] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
189 Schwob E, Hagos Y, Burckhardt G, Burckhardt BC. Transporters involved in renal excretion of N-carbamoylglutamate, an orphan drug to treat inborn n-acetylglutamate synthase deficiency. Am J Physiol Renal Physiol 2014;307:F1373-9. [PMID: 25354943 DOI: 10.1152/ajprenal.00482.2014] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
190 Singh S, Suresh S, Mcclave SA, Cave M. Treating Every Needle in the Haystack: Hyperammonemic Encephalopathy and Severe Malnutrition After Bariatric Surgery—A Case Report and Review of the Literature. JPEN J Parenter Enteral Nutr 2015;39:977-85. [DOI: 10.1177/0148607114546900] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 1.1] [Reference Citation Analysis]
191 Zhou Y, Eid T, Hassel B, Danbolt NC. Novel aspects of glutamine synthetase in ammonia homeostasis. Neurochemistry International 2020;140:104809. [DOI: 10.1016/j.neuint.2020.104809] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
192 Schmidt Z, Murthy G, Ennis M, Stockler‐ipsiroglu S, Elango R. Impact of enteral arginine supplementation on lysine metabolism in humans: A proof‐of‐concept for lysine‐related inborn errors of metabolism. Jrnl of Inher Metab Disea 2020;43:952-9. [DOI: 10.1002/jimd.12233] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
193 Peoc'h K, Damaj L, Pelletier R, Lefèvre C, Dubourg C, Denis MC, Bendavid C, Odent S, Moreau C. Early care of N-acetyl glutamate synthase (NAGS) deficiency in three infants from an inbred family. Mol Genet Metab Rep 2020;22:100558. [PMID: 32021803 DOI: 10.1016/j.ymgmr.2019.100558] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
194 Martinelli D, Fiermonte G, Häberle J, Boenzi S, Goffredo BM, Travaglini L, Agolini E, Porcelli V, Dionisi-Vici C. CUGC for hyperornithinemia-hyperammonemia-homocitrullinuria (HHH) syndrome. Eur J Hum Genet 2020;28:982-7. [PMID: 32242103 DOI: 10.1038/s41431-020-0616-x] [Reference Citation Analysis]
195 Molema F, Gleich F, Burgard P, van der Ploeg AT, Summar ML, Chapman KA, Barić I, Lund AM, Kölker S, Williams M; Additional individual contributors from E-IMD. Evaluation of dietary treatment and amino acid supplementation in organic acidurias and urea-cycle disorders: On the basis of information from a European multicenter registry. J Inherit Metab Dis 2019;42:1162-75. [PMID: 30734935 DOI: 10.1002/jimd.12066] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
196 Cho H. Renal replacement therapy in neonates with an inborn error of metabolism. Korean J Pediatr 2019;62:43-7. [PMID: 30404428 DOI: 10.3345/kjp.2018.07143] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
197 Vanhoorne V, Peeters E, Van Tongelen I, Boussery K, Wynendaele E, De Spiegeleer B, Remon JP, Vervaet C. Pharmaceutical compounding of orphan active ingredients in Belgium: how community and hospital pharmacists can address the needs of patients with rare diseases. Orphanet J Rare Dis 2019;14:186. [PMID: 31370862 DOI: 10.1186/s13023-019-1154-x] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
198 Arora S, Srivastava MVP, Singh MB, Goyal V, Häberle J, Gupta N, Prabhakar A, Aggarwal B, Agarwal A, Vishnu VY. Adult onset type II citrullinemia--a great masquerader. QJM 2020;113:49-51. [PMID: 31532496 DOI: 10.1093/qjmed/hcz238] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
199 Porta F, Romagnoli R, Busso M, Tandoi F, Spada M. Differential Intraoperative Effect of Liver Transplant in Different Inborn Errors of Metabolism. J Pediatr Gastroenterol Nutr 2019;69:160-2. [PMID: 30964822 DOI: 10.1097/MPG.0000000000002354] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
200 Bruno S, Herrera Sanchez MB, Chiabotto G, Fonsato V, Navarro-Tableros V, Pasquino C, Tapparo M, Camussi G. Human Liver Stem Cells: A Liver-Derived Mesenchymal Stromal Cell-Like Population With Pro-regenerative Properties. Front Cell Dev Biol 2021;9:644088. [PMID: 33981703 DOI: 10.3389/fcell.2021.644088] [Reference Citation Analysis]
201 Reigstad H, Woldseth B, Häberle J. Normal Neurological Development During Infancy Despite Massive Hyperammonemia in Early Treated NAGS Deficiency. JIMD Rep 2017;37:45-7. [PMID: 28275973 DOI: 10.1007/8904_2017_13] [Cited by in Crossref: 3] [Article Influence: 0.6] [Reference Citation Analysis]
202 van Wegberg AMJ, MacDonald A, Ahring K, Bélanger-Quintana A, Blau N, Bosch AM, Burlina A, Campistol J, Feillet F, Giżewska M, Huijbregts SC, Kearney S, Leuzzi V, Maillot F, Muntau AC, van Rijn M, Trefz F, Walter JH, van Spronsen FJ. The complete European guidelines on phenylketonuria: diagnosis and treatment. Orphanet J Rare Dis 2017;12:162. [PMID: 29025426 DOI: 10.1186/s13023-017-0685-2] [Cited by in Crossref: 206] [Cited by in F6Publishing: 167] [Article Influence: 41.2] [Reference Citation Analysis]
203 Larson AA, Balasubramaniam S, Christodoulou J, Burrage LC, Marom R, Graham BH, Diaz GA, Glamuzina E, Hauser N, Heese B, Horvath G, Mattman A, van Karnebeek C, Lane Rutledge S, Williamson A, Estrella L, Van Hove JKL, Weisfeld-Adams JD. Biochemical signatures mimicking multiple carboxylase deficiency in children with mutations in MT-ATP6. Mitochondrion 2019;44:58-64. [PMID: 29307858 DOI: 10.1016/j.mito.2018.01.001] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
204 Harthan AA. An Introduction to Pharmacotherapy for Inborn Errors of Metabolism. J Pediatr Pharmacol Ther 2018;23:432-46. [PMID: 30697128 DOI: 10.5863/1551-6776-23.6.432] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
205 Baruteau J, Jameson E, Morris AA, Chakrapani A, Santra S, Vijay S, Kocadag H, Beesley CE, Grunewald S, Murphy E, Cleary M, Mundy H, Abulhoul L, Broomfield A, Lachmann R, Rahman Y, Robinson PH, MacPherson L, Foster K, Chong WK, Ridout DA, Bounford KM, Waddington SN, Mills PB, Gissen P, Davison JE. Expanding the phenotype in argininosuccinic aciduria: need for new therapies. J Inherit Metab Dis 2017;40:357-68. [PMID: 28251416 DOI: 10.1007/s10545-017-0022-x] [Cited by in Crossref: 38] [Cited by in F6Publishing: 33] [Article Influence: 7.6] [Reference Citation Analysis]
206 Alqarajeh F, Omorodion J, Bosfield K, Shur N, Ferreira CR. Lysinuric protein intolerance: Pearls to detect this otherwise easily missed diagnosis. Transl Sci Rare Dis 2020;5:81-6. [PMID: 33134088 DOI: 10.3233/TRD-190035] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
207 Posset R, Garcia-Cazorla A, Valayannopoulos V, Teles EL, Dionisi-Vici C, Brassier A, Burlina AB, Burgard P, Cortès-Saladelafont E, Dobbelaere D, Couce ML, Sykut-Cegielska J, Häberle J, Lund AM, Chakrapani A, Schiff M, Walter JH, Zeman J, Vara R, Kölker S; Additional individual contributors of the E-IMD consortium. Age at disease onset and peak ammonium level rather than interventional variables predict the neurological outcome in urea cycle disorders. J Inherit Metab Dis 2016;39:661-72. [PMID: 27106216 DOI: 10.1007/s10545-016-9938-9] [Cited by in Crossref: 40] [Cited by in F6Publishing: 32] [Article Influence: 6.7] [Reference Citation Analysis]
208 Choi JJ, Kim HS, Lee KC, Shin Y, Jo YY. Anesthetic experience of an adult male with citrullinemia type II: a case report. BMC Anesthesiol 2016;16:92. [PMID: 27724842 DOI: 10.1186/s12871-016-0253-7] [Cited by in Crossref: 3] [Article Influence: 0.5] [Reference Citation Analysis]
209 Vajro P, Ferrante L, Lenta S, Mandato C, Persico M. Management of adults with paediatric-onset chronic liver disease: strategic issues for transition care. Dig Liver Dis 2014;46:295-301. [PMID: 24321359 DOI: 10.1016/j.dld.2013.10.018] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 1.9] [Reference Citation Analysis]
210 Sancho-vaello E, Marco-marín C, Gougeard N, Fernández-murga L, Rüfenacht V, Mustedanagic M, Rubio V, Häberle J. Understanding N-Acetyl-L-Glutamate Synthase Deficiency: Mutational Spectrum, Impact of Clinical Mutations on Enzyme Functionality, and Structural Considerations. Human Mutation 2016;37:679-94. [DOI: 10.1002/humu.22995] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 3.3] [Reference Citation Analysis]
211 Kölker S, Dobbelaere D, Häberle J, Burgard P, Gleich F, Summar ML, Hannigan S, Parker S, Chakrapani A, Baumgartner MR; E-IMD Consortium. Networking Across Borders for Individuals with Organic Acidurias and Urea Cycle Disorders: The E-IMD Consortium. JIMD Rep 2015;22:29-38. [PMID: 25701269 DOI: 10.1007/8904_2015_408] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 2.3] [Reference Citation Analysis]
212 Molina Gutiérrez MA, López López R, Morais López A, Bueno Barriocanal M, Martínez Ojinaga Nodal E, Alcolea Sánchez AM, García García S. [Inherited metabolic disorders in pediatric emergency services]. An Pediatr (Barc) 2015;82:404-11. [PMID: 25488173 DOI: 10.1016/j.anpedi.2014.09.013] [Reference Citation Analysis]
213 Cavino K, Sung B, Su Q, Na E, Kim J, Cheng X, Gromada J, Okamoto H. Glucagon Receptor Inhibition Reduces Hyperammonemia and Lethality in Male Mice with Urea Cycle Disorder. Endocrinology 2021;162:bqaa211. [PMID: 33206168 DOI: 10.1210/endocr/bqaa211] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
214 Unsinn C, Das A, Valayannopoulos V, Thimm E, Beblo S, Burlina A, Konstantopoulou V, Mayorandan S, de Lonlay P, Rennecke J, Derbinski J, Hoffmann GF, Häberle J. Clinical course of 63 patients with neonatal onset urea cycle disorders in the years 2001-2013. Orphanet J Rare Dis 2016;11:116. [PMID: 27538463 DOI: 10.1186/s13023-016-0493-0] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 4.2] [Reference Citation Analysis]
215 Demirdas S, van Kessel IN, Korndewal MJ, Hollak CE, Meutgeert H, Klaren A, van Rijn M, van Spronsen FJ, Bosch AM; Dutch working Group. Clinical pathways for inborn errors of metabolism: warranted and feasible. Orphanet J Rare Dis 2013;8:37. [PMID: 23442887 DOI: 10.1186/1750-1172-8-37] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
216 Yeoh C, Teng H, Jackson J, Hingula L, Irie T, Legler A, Levine C, Chu I, Chai C, Tollinche L. Metabolic Disorders and Anesthesia. Curr Anesthesiol Rep 2019;9:340-59. [PMID: 31406490 DOI: 10.1007/s40140-019-00345-w] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
217 Posset R, Garbade SF, Boy N, Burlina AB, Dionisi-Vici C, Dobbelaere D, Garcia-Cazorla A, de Lonlay P, Teles EL, Vara R, Mew NA, Batshaw ML, Baumgartner MR, McCandless SE, Seminara J, Summar M, Hoffmann GF, Kölker S, Burgard P; Additional individual contributors of the UCDC and the E-IMD consortium. Transatlantic combined and comparative data analysis of 1095 patients with urea cycle disorders-A successful strategy for clinical research of rare diseases. J Inherit Metab Dis 2019;42:93-106. [PMID: 30740724 DOI: 10.1002/jimd.12031] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 8.0] [Reference Citation Analysis]
218 Nguyen HH, Khanh Nguyen N, Dung Vu C, Thu Huong Nguyen T, Nguyen NL. Late-Onset Ornithine Transcarbamylase Deficiency and Variable Phenotypes in Vietnamese Females With OTC Mutations. Front Pediatr 2020;8:321. [PMID: 32793520 DOI: 10.3389/fped.2020.00321] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
219 Karthikeyan G, Jagadeesh S, Seshadri S, Häberle J. Citrullinemia type 1: genetic diagnosis and prenatal diagnosis in subsequent pregnancy. Indian Pediatr 2013;50:965-6. [PMID: 24222285 DOI: 10.1007/s13312-013-0239-1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
220 Eloot S, De Rudder J, Verloo P, Dhont E, Raes A, Van Biesen W, Snauwaert E. Towards an Algorithm-Based Tailored Treatment of Acute Neonatal Hyperammonemia. Toxins (Basel) 2021;13:484. [PMID: 34357956 DOI: 10.3390/toxins13070484] [Reference Citation Analysis]
221 Chen X, Yuan L, Sun M, Liu Q, Wu Y. Two novel CPS1 mutations in a case of carbamoyl phosphate synthetase 1 deficiency causing hyperammonemia and leukodystrophy. J Clin Lab Anal 2018;32:e22375. [PMID: 29314318 DOI: 10.1002/jcla.22375] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
222 Leger RF, Silverman MS, Hauck ES, Guvakova KD. Hyperammonemia Post Lung Transplantation: A Review. Clin Med Insights Circ Respir Pulm Med 2020;14:1179548420966234. [PMID: 33192115 DOI: 10.1177/1179548420966234] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
223 Ikeri K, Cardona VQ, Hagan-Brown A, Young M, Schneider M, Menkiti O. ECMO as a Platform for Rapid Ammonia Removal in a Neonate with Multienzyme Urea Cycle Disorder. J Extra Corpor Technol 2020;52:58-62. [PMID: 32280145 DOI: 10.1182/JECT-1900032] [Reference Citation Analysis]
224 Kim JH, Kim YM, Lee BH, Cho JH, Kim GH, Choi JH, Yoo HW. Short-term efficacy of N-carbamylglutamate in a patient with N-acetylglutamate synthase deficiency. J Hum Genet 2015;60:395-7. [PMID: 25787344 DOI: 10.1038/jhg.2015.30] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
225 Pizzi MA, Alejos D, Hasan TF, Atwal PS, Krishnaiengar SR, Freeman WD. Adult Presentation of Ornithine Transcarbamylase Deficiency: 2 Illustrative Cases of Phenotypic Variability and Literature Review. Neurohospitalist 2019;9:30-6. [PMID: 30671162 DOI: 10.1177/1941874418764817] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
226 Waisbren SE, Stefanatos AK, Kok TMY, Ozturk-Hismi B. Neuropsychological attributes of urea cycle disorders: A systematic review of the literature. J Inherit Metab Dis 2019;42:1176-91. [PMID: 31268178 DOI: 10.1002/jimd.12146] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
227 Perito ER, Rhee S, Roberts JP, Rosenthal P. Pediatric liver transplantation for urea cycle disorders and organic acidemias: United Network for Organ Sharing data for 2002-2012. Liver Transpl. 2014;20:89-99. [PMID: 24136671 DOI: 10.1002/lt.23765] [Cited by in Crossref: 38] [Cited by in F6Publishing: 30] [Article Influence: 4.2] [Reference Citation Analysis]
228 Gambello MJ, Li H. Current strategies for the treatment of inborn errors of metabolism. J Genet Genomics 2018;45:61-70. [PMID: 29500085 DOI: 10.1016/j.jgg.2018.02.001] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 4.3] [Reference Citation Analysis]
229 Lee B, Diaz GA, Rhead W, Lichter-Konecki U, Feigenbaum A, Berry SA, Le Mons C, Bartley J, Longo N, Nagamani SC, Berquist W, Gallagher RC, Harding CO, McCandless SE, Smith W, Schulze A, Marino M, Rowell R, Coakley DF, Mokhtarani M, Scharschmidt BF. Glutamine and hyperammonemic crises in patients with urea cycle disorders. Mol Genet Metab 2016;117:27-32. [PMID: 26586473 DOI: 10.1016/j.ymgme.2015.11.005] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.7] [Reference Citation Analysis]
230 Xu J, Zhang A, Huang F. Biallelic mutations in carbamoyl phosphate synthetase 1 induced hyperammonemia in a neonate: A case report. Exp Ther Med 2020;20:623-9. [PMID: 32537019 DOI: 10.3892/etm.2020.8717] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
231 Foschi FG, Morelli MC, Savini S, Dall’Aglio AC, Lanzi A, Cescon M, Ercolani G, Cucchetti A, Pinna AD, Stefanini GF. Urea cycle disorders: A case report of a successful treatment with liver transplant and a literature review. World J Gastroenterol 2015; 21(13): 4063-4068 [PMID: 25852294 DOI: 10.3748/wjg.v21.i13.4063] [Cited by in CrossRef: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
232 Ezgu F. Inborn Errors of Metabolism. Elsevier; 2016. pp. 195-250. [DOI: 10.1016/bs.acc.2015.12.001] [Cited by in Crossref: 24] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
233 Grünewald S, Davison J, Martinelli D, Duran M, Dionisi-vici C. Emergency Diagnostic Procedures and Emergency Treatment. In: Blau N, Duran M, Gibson KM, Dionisi Vici C, editors. Physician's Guide to the Diagnosis, Treatment, and Follow-Up of Inherited Metabolic Diseases. Berlin: Springer Berlin Heidelberg; 2014. pp. 709-17. [DOI: 10.1007/978-3-642-40337-8_45] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
234 Van Leynseele A, Jansen A, Goyens P, Martens G, Peeters S, Jonckheere A, De Meirleir L. Early treatment of a child with NAGS deficiency using N-carbamyl glutamate results in a normal neurological outcome. Eur J Pediatr 2014;173:1635-8. [PMID: 24233332 DOI: 10.1007/s00431-013-2205-2] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
235 Billingham MJ, Rizk R. Role of early management of hyperornithinaemia-hyperammonaemia-homocitrullinuria syndrome in pregnancy. BMJ Case Rep 2021;14:e241424. [PMID: 34210698 DOI: 10.1136/bcr-2020-241424] [Reference Citation Analysis]
236 Sin YY, Baron G, Schulze A, Funk CD. Arginase-1 deficiency. J Mol Med (Berl) 2015;93:1287-96. [PMID: 26467175 DOI: 10.1007/s00109-015-1354-3] [Cited by in F6Publishing: 28] [Reference Citation Analysis]
237 Janzen N, Terhardt M, Sander S, Demirkol M, Gökçay G, Peter M, Lücke T, Sander J, Das AM. Towards newborn screening for ornithine transcarbamylase deficiency: Fast non-chromatographic orotic acid quantification from dried blood spots by tandem mass spectrometry. Clinica Chimica Acta 2014;430:28-32. [DOI: 10.1016/j.cca.2013.12.020] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
238 D'Amora P, Silva IDCG, Budib MA, Ayache R, Silva RMS, Silva FC, Appel RM, Júnior SS, Pontes HBD, Alvarenga AC, Arima EC, Martins WG, Silva NLF, Diaz RS, Salzgeber MB, Palma AM, Evans SS, Nagourney RA. Towards risk stratification and prediction of disease severity and mortality in COVID-19: Next generation metabolomics for the measurement of host response to COVID-19 infection. PLoS One 2021;16:e0259909. [PMID: 34851990 DOI: 10.1371/journal.pone.0259909] [Reference Citation Analysis]
239 Rokicki D, Pajdowska M, Trubicka J, Thong M, Ciara E, Piekutowska-abramczuk D, Pronicki M, Sikora R, Haidar R, Ołtarzewski M, Jabłońska E, Muthukumarasamy P, Sthaneswar P, Gan C, Krajewska-walasek M, Carrozzo R, Verrigni D, Semeraro M, Rizzo C, Taurisano R, Alhaddad B, Kovacs-nagy R, Haack TB, Dionisi-vici C, Pronicka E, Wortmann SB. 3-Methylglutaconic aciduria, a frequent but underrecognized finding in carbamoyl phosphate synthetase I deficiency. Clinica Chimica Acta 2017;471:95-100. [DOI: 10.1016/j.cca.2017.05.023] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
240 Burlina A, Cazzorla C, Zanonato E, Viggiano E, Fasan I, Polo G. Clinical experience with N-carbamylglutamate in a single-centre cohort of patients with propionic and methylmalonic aciduria. Mol Genet Metab Rep 2016;8:34-40. [PMID: 27489777 DOI: 10.1016/j.ymgmr.2016.06.007] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 2.5] [Reference Citation Analysis]
241 Evans M, Truby H, Boneh A. The Relationship between Dietary Intake, Growth, and Body Composition in Inborn Errors of Intermediary Protein Metabolism. The Journal of Pediatrics 2017;188:163-72. [DOI: 10.1016/j.jpeds.2017.05.048] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 3.6] [Reference Citation Analysis]
242 Häberle J, Burlina A, Chakrapani A, Dixon M, Karall D, Lindner M, Mandel H, Martinelli D, Pintos-Morell G, Santer R, Skouma A, Servais A, Tal G, Rubio V, Huemer M, Dionisi-Vici C. Suggested guidelines for the diagnosis and management of urea cycle disorders: First revision. J Inherit Metab Dis 2019;42:1192-230. [PMID: 30982989 DOI: 10.1002/jimd.12100] [Cited by in Crossref: 93] [Cited by in F6Publishing: 76] [Article Influence: 31.0] [Reference Citation Analysis]
243 Jain-Ghai S, Joffe AR, Bond GY, Siriwardena K, Chan A, Yap JYK, Hajihosseini M, Dinu IA, Acton BV, Robertson CMT; Western Canadian Complex Pediatric Therapies Follow‐up Group. Pre-school neurocognitive and functional outcomes after liver transplant in children with early onset urea cycle disorders, maple syrup urine disease, and propionic acidemia: An inception cohort matched-comparison study. JIMD Rep 2020;52:43-54. [PMID: 32154059 DOI: 10.1002/jmd2.12095] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
244 Rivera-Barahona A, Sánchez-Alcudia R, Viecelli HM, Rüfenacht V, Pérez B, Ugarte M, Häberle J, Thöny B, Desviat LR. Functional characterization of the spf/ash splicing variation in OTC deficiency of mice and man. PLoS One 2015;10:e0122966. [PMID: 25853564 DOI: 10.1371/journal.pone.0122966] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.9] [Reference Citation Analysis]
245 Ichord RN, Bearden DR. Perinatal Metabolic Encephalopathies. Swaiman's Pediatric Neurology. Elsevier; 2017. pp. 171-7. [DOI: 10.1016/b978-0-323-37101-8.00023-0] [Cited by in Crossref: 3] [Article Influence: 0.6] [Reference Citation Analysis]
246 Yang X, Shi J, Lei H, Xia B, Mu D. Neonatal-onset carbamoyl phosphate synthetase I deficiency: A case report. Medicine (Baltimore) 2017;96:e7365. [PMID: 28658158 DOI: 10.1097/MD.0000000000007365] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
247 Solares I, Heredia-Mena C, Castelbón FJ, Jericó D, Córdoba KM, Fontanellas A, Enríquez de Salamanca R, Morales-Conejo M. Diagnosis and Management of Inborn Errors of Metabolism in Adult Patients in the Emergency Department. Diagnostics (Basel) 2021;11:2148. [PMID: 34829496 DOI: 10.3390/diagnostics11112148] [Reference Citation Analysis]
248 Boenzi S, Pastore A, Martinelli D, Goffredo BM, Boiani A, Rizzo C, Dionisi-vici C. Creatine metabolism in urea cycle defects. J Inherit Metab Dis 2012;35:647-53. [DOI: 10.1007/s10545-012-9494-x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 1.8] [Reference Citation Analysis]
249 Matoori S, Leroux JC. Recent advances in the treatment of hyperammonemia. Adv Drug Deliv Rev 2015;90:55-68. [PMID: 25895618 DOI: 10.1016/j.addr.2015.04.009] [Cited by in Crossref: 58] [Cited by in F6Publishing: 46] [Article Influence: 8.3] [Reference Citation Analysis]
250 Kloesel B, Holzman RS. Anesthetic Management of Patients With Inborn Errors of Metabolism: . Anesthesia & Analgesia 2017;125:822-36. [DOI: 10.1213/ane.0000000000001689] [Cited by in Crossref: 14] [Article Influence: 2.8] [Reference Citation Analysis]
251 Koga R, Miyoshi Y, Sato Y, Mita M, Konno R, Lindner W, Hamase K. Enantioselective determination of citrulline and ornithine in the urine of d -amino acid oxidase deficient mice using a two-dimensional high-performance liquid chromatographic system. Journal of Chromatography A 2016;1467:312-7. [DOI: 10.1016/j.chroma.2016.07.053] [Cited by in Crossref: 20] [Cited by in F6Publishing: 14] [Article Influence: 3.3] [Reference Citation Analysis]
252 Kwon JM. Testing for Inborn Errors of Metabolism. Continuum (Minneap Minn) 2018;24:37-56. [PMID: 29432236 DOI: 10.1212/CON.0000000000000563] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
253 Saritaş Nakip Ö, Yıldız Y, Tokatlı A. Retrospective evaluation of 85 patients with urea cycle disorders: one center experience, three new mutations. J Pediatr Endocrinol Metab 2020;33:721-8. [PMID: 32447331 DOI: 10.1515/jpem-2019-0413] [Reference Citation Analysis]
254 Wells DL, Thomas JB, Sacks GS, Zouhary LA. Late-onset urea cycle disorder in adulthood unmasked by severe malnutrition. Nutrition 2014;30:943-7. [PMID: 24985015 DOI: 10.1016/j.nut.2013.12.011] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
255 Oishi K, Diaz GA. Glycerol phenylbutyrate for the chronic management of urea cycle disorders. Expert Rev Endocrinol Metab 2014;9:427-34. [PMID: 30736206 DOI: 10.1586/17446651.2014.945908] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
256 Sánchez AI, Rincón A, García M, Suárez-Obando F. Urea Cycle Defects: Early-Onset Disease Associated with A208T Mutation in OTC Gene-Expanding the Clinical Phenotype. Case Rep Genet 2017;2017:1048717. [PMID: 28261508 DOI: 10.1155/2017/1048717] [Reference Citation Analysis]
257 Pizarro MD, Mamprin ME, Daurelio LD, Rodriguez JV, Mediavilla MG. Experimental bio-artificial liver: Importance of the architectural design on ammonia detoxification performance. World J Hepatol 2018; 10(10): 719-730 [PMID: 30386465 DOI: 10.4254/wjh.v10.i10.719] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
258 Schlickmann DS, Molz P, Brand C, Dos Santos C, da Silva TG, Rieger A, Benito PJ, Reuter CP, Renner JDP, Rech Franke SI. Liver and kidney function markers among gym users: the role of dietary supplement usage. Br J Nutr 2021;:1-8. [PMID: 34511159 DOI: 10.1017/S0007114521003652] [Reference Citation Analysis]
259 Molema F, Martinelli D, Hörster F, Kölker S, Tangeraas T, de Koning B, Dionisi-Vici C, Williams M; additional individual contributors of MetabERN. Liver and/or kidney transplantation in amino and organic acid-related inborn errors of metabolism: An overview on European data. J Inherit Metab Dis 2021;44:593-605. [PMID: 32996606 DOI: 10.1002/jimd.12318] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
260 Arpaci T, Altay N, Toruner EK, Gunduz M. Symptoms and Problems in Children with Inherited Metabolic Diseases and Factors Affecting the Caregiver Burden of Mothers. Comprehensive Child and Adolescent Nursing 2020;43:363-77. [DOI: 10.1080/24694193.2019.1687611] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
261 Buerger C, Garbade SF, Dietrich Alber F, Waisbren SE, McCarter R, Kölker S, Burgard P; Urea Cycle Disorders Consortium. Impairment of cognitive function in ornithine transcarbamylase deficiency is global rather than domain-specific and is associated with disease onset, sex, maximum ammonium, and number of hyperammonemic events. J Inherit Metab Dis 2019;42:243-53. [PMID: 30671983 DOI: 10.1002/jimd.12013] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
262 Diez-fernandez C, Martínez AI, Pekkala S, Barcelona B, Pérez-arellano I, Guadalajara AM, Summar M, Cervera J, Rubio V. Molecular Characterization of Carbamoyl-Phosphate Synthetase (CPS1) Deficiency Using Human Recombinant CPS1 as a Key Tool. Human Mutation 2013;34:1149-59. [DOI: 10.1002/humu.22349] [Cited by in Crossref: 30] [Cited by in F6Publishing: 29] [Article Influence: 3.3] [Reference Citation Analysis]
263 Mohamed S, Hamad MH, Kondkar AA, Abu-Amero KK. A novel mutation in ornithine transcarbamylase gene causing mild intermittent hyperammonemia. Saudi Med J 2015;36:1229-32. [PMID: 26446336 DOI: 10.15537/smj.2015.10.12127] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
264 Valayannopoulos V, Baruteau J, Delgado MB, Cano A, Couce ML, Del Toro M, Donati MA, Garcia-Cazorla A, Gil-Ortega D, Gomez-de Quero P, Guffon N, Hofstede FC, Kalkan-Ucar S, Coker M, Lama-More R, Martinez-Pardo Casanova M, Molina A, Pichard S, Papadia F, Rosello P, Plisson C, Le Mouhaer J, Chakrapani A. Carglumic acid enhances rapid ammonia detoxification in classical organic acidurias with a favourable risk-benefit profile: a retrospective observational study. Orphanet J Rare Dis 2016;11:32. [PMID: 27030250 DOI: 10.1186/s13023-016-0406-2] [Cited by in Crossref: 24] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
265 Goldstein A, Vockley J. Clinical trials examining treatments for inborn errors of amino acid metabolism. Expert Opinion on Orphan Drugs 2016;5:153-64. [DOI: 10.1080/21678707.2017.1275565] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
266 Chan CCH, Kukreti V, Inbar-Feigenberg M, Adrian-Gutierrez J. Ataxia and confusion in a 10-year-old girl. Paediatr Child Health 2021;26:137-8. [PMID: 33936329 DOI: 10.1093/pch/pxaa058] [Reference Citation Analysis]
267 Feldman B, Tuchman M, Caldovic L. A zebrafish model of hyperammonemia. Mol Genet Metab 2014;113:142-7. [PMID: 25069822 DOI: 10.1016/j.ymgme.2014.07.001] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
268 Kido J, Matsumoto S, Momosaki K, Sakamoto R, Mitsubuchi H, Endo F, Nakamura K. Liver transplantation may prevent neurodevelopmental deterioration in high-risk patients with urea cycle disorders. Pediatr Transplantation 2017;21:e12987. [DOI: 10.1111/petr.12987] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
269 Smets F, Dobbelaere D, McKiernan P, Dionisi-Vici C, Broué P, Jacquemin E, Lopes AI, Gonçalves I, Mandel H, Pawlowska J, Kamińska D, Shteyer E, Torre G, Shapiro R, Eyskens F, Clapuyt P, Gissen P, Pariente D, Grunewald S, Yudkoff M, Binda MM, Najimi M, Belmonte N, de Vos B, Thonnard J, Sokal E. Phase I/II Trial of Liver-derived Mesenchymal Stem Cells in Pediatric Liver-based Metabolic Disorders: A Prospective, Open Label, Multicenter, Partially Randomized, Safety Study of One Cycle of Heterologous Human Adult Liver-derived Progenitor Cells (HepaStem) in Urea Cycle Disorders and Crigler-Najjar Syndrome Patients. Transplantation 2019;103:1903-15. [PMID: 30801523 DOI: 10.1097/TP.0000000000002605] [Cited by in Crossref: 23] [Cited by in F6Publishing: 16] [Article Influence: 11.5] [Reference Citation Analysis]
270 Maric S, Restin T, Muff JL, Camargo SM, Guglielmetti LC, Holland-Cunz SG, Crenn P, Vuille-Dit-Bille RN. Citrulline, Biomarker of Enterocyte Functional Mass and Dietary Supplement. Metabolism, Transport, and Current Evidence for Clinical Use. Nutrients 2021;13:2794. [PMID: 34444954 DOI: 10.3390/nu13082794] [Reference Citation Analysis]
271 Forny P, Schumann A, Mustedanagic M, Mathis D, Wulf MA, Nägele N, Langhans CD, Zhakupova A, Heeren J, Scheja L, Fingerhut R, Peters HL, Hornemann T, Thony B, Kölker S, Burda P, Froese DS, Devuyst O, Baumgartner MR. Novel Mouse Models of Methylmalonic Aciduria Recapitulate Phenotypic Traits with a Genetic Dosage Effect. J Biol Chem 2016;291:20563-73. [PMID: 27519416 DOI: 10.1074/jbc.M116.747717] [Cited by in Crossref: 18] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
272 Walker V. Ammonia metabolism and hyperammonemic disorders. Adv Clin Chem. 2014;67:73-150. [PMID: 25735860 DOI: 10.1016/bs.acc.2014.09.002] [Cited by in Crossref: 41] [Cited by in F6Publishing: 39] [Article Influence: 5.1] [Reference Citation Analysis]
273 Martinelli D, Diodato D, Ponzi E, Monné M, Boenzi S, Bertini E, Fiermonte G, Dionisi-Vici C. The hyperornithinemia-hyperammonemia-homocitrullinuria syndrome. Orphanet J Rare Dis 2015;10:29. [PMID: 25874378 DOI: 10.1186/s13023-015-0242-9] [Cited by in Crossref: 41] [Cited by in F6Publishing: 28] [Article Influence: 5.9] [Reference Citation Analysis]
274 Piper JD, Piper PW. Benzoate and Sorbate Salts: A Systematic Review of the Potential Hazards of These Invaluable Preservatives and the Expanding Spectrum of Clinical Uses for Sodium Benzoate. Compr Rev Food Sci Food Saf 2017;16:868-80. [PMID: 33371618 DOI: 10.1111/1541-4337.12284] [Cited by in Crossref: 41] [Cited by in F6Publishing: 17] [Article Influence: 8.2] [Reference Citation Analysis]
275 Ramanathan M, Uppalapu S, Patel NM. Hiding in Plain Sight: A Case of Ornithine Transcarbamylase Deficiency Unmasked Post-Liver Transplantation. Am J Transplant 2017;17:1405-8. [DOI: 10.1111/ajt.14174] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
276 MacLeod EL, Hall KD, McGuire PJ. Computational modeling to predict nitrogen balance during acute metabolic decompensation in patients with urea cycle disorders. J Inherit Metab Dis 2016;39:17-24. [PMID: 26260782 DOI: 10.1007/s10545-015-9882-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]